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Summary 
I nteraction of antiviral drugs and ligand molecules with nucleic acids and 
oligonucleotides and its applications, is one of the hot interesting research scientific 
topics. Therefore, it has attracted many scientific research groups. Nucleic acids are 
arguably the most important of all biomolecules. The unique complementary structure of 
DNA between the base pairs adenine/thymine and cytosine/guanine has been the basis for 
genetic analysis over the last few decades. The ability of a single stranded DNA (ssONA) 
molecule to seek out or hybridize its complementary strand in a sample is the foundation 
of DNA based detection systems. Meanwhile, antiviral drugs act by different mechanisms 
on RNA and DNA. These include inhibitions of nucleic acid synthesis, attachment to host 
cells andlor protein acid synthesis. 
I n  this work, some antiviral drugs as well as some ligand molecules have been 
chosen for studying their interaction with DNA. These compounds included 5-iod02'­
deoxyuridine, Rifampicin, Levofloxacin, and ABTS. The aim of this study was to study 
the mechanisms of interaction of different DNA sequences (011, 012, Cs, C6) their 
duplexes, ct-DNA and human sample DNA) with the four mentioned drugs and ligands. 
Interactions were studied using spectrophotometric and fluoremetric methods. 
ext paragraphs give ideas and succinct description for each chapter of the thesis: 
I. Chapter 1, I ntroduction, include a general and updated literature survey on nucleic 
acid/drug interactions, analytical techniques used for this purposes, binding modes with 
drug and nucleic acid, DNA biosensors and their applications. Also an updated survey for 
the four drugs used in this work 
2. Chapter I I , Experimental, include a description of experimental procedures, 
instrumentation used, materials and reagents, preparation of the various standard and 
buffer solutions and finally a description of the spectrophotometric and fluoremetric 
procedures used. 
3. Chapter I II, Results and discussions: this chapter discussed the spectrophotometric 
characterization of the interaction selected between nucleic acids and investigated drugs, 
ligands, and compunds. The following themes have been studied and discussed: 
I .  haracteristics of UV -spectra for some drugs interacted with different nucleic acids , 
and mechanism of interactions. 
2. Optimization of reaction conditions included reaction time and stability, addition order 
of reagents, effect of incubation time and temperature. 
3. Molar ratio, dynamic range and sensitivity were also. It was proven that nucleic acids/ 
drugs intercalates b I :  1 mass/ratio. Dynamic ranges varies from I -8 for different 
intercalates. Decreasing of the absorbance by adding the successive amounts of the 
nucleic acids to drugs gives an indication about the mode of the interactions which is 
probably intercalation. 
4. electivity was tested by interaction of twelve interferences agents with ct-DNA and 
(ABTS). Significant to insignificant interferences were detected. 
5. Discussion of the interaction mechanism revealed intercalation of the drugs/compounds 
between nucleic acids base pairs. 
Chapter I V: Result and discussions. Fluoremetric characterization of investigated 
intercalates. I n  this part, the following themes have been studied and discussed. 
I .  Characteristics of fluorescence-spectra for Rifampicin and ABTS interacted with ct­
D A, and their mechanisms of interactions. 
2. Optimization of reaction conditions include the effect of different pHs (ranges from 4-
7) and concentrations (5, 10, 15, 20 30 and 50 ppm). The results indicated that the 
concentrations (5, 10, and I S) in addition to pH 7 are the optimum conditions for the 
interaction of the previously mentioned compounds. Reaction time, stability, addition 
order of reagents, effect of incubation time and stability were also investigated. It was 
proved that adding ct-DNA to rifampicin or ABTS resulted in decreases in intensity of the 
fluorescence intensities. The reason was attributed to the intercalation between 
drugs/investigated compound and ct-DNA. 
3. The mass/ratio between rifampicin or ABTS and nucleic acids was proved to be I :  1 
Drug/DNA. 
4. I nterference of twelve interfering agents on ABTS-Nucleic acids was investigated. The 
results showed significant to insignificant interferences which reflect selectivity of the 
proposed methods. 
5. Discussion of the interaction mechanisms. Quenching in the fluorescence intensity 
upon addition of nucleic acids has proven that drugs/compounds and the nucleic acid are 
interacted in an intercalation and/or electrostatic modes. 
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475 nm a s  Amax of em i ssion in pho sphate bu ffer pH 7 .  
Fig. 4.1.2h. E ffect of concentration of r ifampic in on fluore scence i nten sity mea sured at 
670 nm a s  Amax of emi ssion in  pho sphate buffer pH 7 .  
Fig. 4.1.2a. Fluore scence spectra obtained by succe ssive add it ion s of 200, 600 1 000 III 
port ion of 5 Ilg/m l ct-D A to 1 .0 ml of 5 ).1.g/m l ri fampic in in  pho sphate bu ffer pH 7. 
The pectra were mea sured at 235 nm a s  "'ma>. of exc i tation in ( ) ) and at 3 3 5  nm a s  "'max 
of exc itation in ( J I  ) . 
Fig. 4.1.2b. Fluore cence spectra obta ined by succe ssive addi t ion s of 200, 600, J 000 ).1.1 
po rtion s of 1 0 �lg/m l ct-DNA to 1 .0 m l  of 1 0  ).1.glm l ri fampic in in pho sphate buffer pH 7. 
The pectra were mea sured at 235  nm a s  "'max of exc itat ion in ( I ) and at 335  nm a s  "-max 
of exc itat ion in ( 1 1  ) .  
Fig. 4.1.2c. F luore scence spectra obta i ned by succe ssive addit ion s of 200, 600, 1 000 ).1.1 
port ion s of 1 5  /lg/m l ct-DNA to 1 .0 m l  of 1 5  ).1.g/m l ri fampic in in pho sphate buffer pH 7 .  
The spectra were mea sured at  235  nm a s  "'max of exc itat ion in  ( 1 ) and at  335  nm a s  "'max 
of excitation in ( I I  ) .  
F i g .  4.1.2d. F luore scence spectra obtained by succe ssive addit ion s of 200, 600, 1 000 ).1.1 
port ion s of 20 ).1.g/m l ct-DNA to 1 .0 m l  of 20 ).1.g/m l ri fampic in  in pho sphate buffer pH 7 .  
The spectra were mea sured at  235  nm a s  "'max of exc itation in  ( ] ) and at 335 nm a s  "'max 
of exc i tation in ( Il ) . 
Fig. 4.1.2e. F l uore scence spectra obta ined by succe ssive addit ion s of 200, 600, 1 000 ).1.1 
port ion s of 30  ).1.g/m l ct-DNA to 1 .0 m l  of 30 ).1.g /m l ri fampic i n  in pho sphate buffer pH 7. 
The spectra were mea sured at 235  nm a s  "-max of exc itation i n  ( ] ) and at 335  nm a s  "'max 
of exc i tat ion in ( IJ ) . 
Fig. 4.1.2f. F luore scence spectra obta ined by succe ssive add i t ion s of 200, 600, 1 000 ).1.1 
port ion s of 50 /lg/m l ct-DNA to 1 .0 m l  of 50 ).1.g/m l r ifampic in  in pho sphate buffer pH 7. 
The spectra were mea sured at 235  nm a s  "-max of exc i tat ion in ( J ) and at 3 3 5  nm a s  "-max 
of exc itation i n  ( 1 1  ) .  
Fig. 4.1.3.1a. F luore scence spectra obtained by succe ssive addi t ion s of 200, 600, 1 000 ).1.1 
portion s of 1 0  ).1.g/m l ct-DNA to 1 .0 m l  of 1 0  ).1.g/m l r ifampic in  in pho sphate buffer pH 4 .  
The spectra were mea sured at 2 3 5  n m  a s  "'max of exc itation in ( I ) and at 335  nm a s  "'ma>. 
of exc i tation i n  ( I I  ) .  
Fig. 4.1.3.1b. F luorescence spectra obtained by successive add i t ions of 200, 600, 1 000 )..t l 
port ions of 1 0  )..tg/m l ct-DNA to J .O m l  of 1 0  )..tg/m l ri fampic in  in phosphate bu ffer pH 5 .  
The p ctra were measured at 235  nm as "'max of exc itat ion in ( I ) and at 3 3 5  nm as Amax 
of e ital ion in ( Il ) . 
Fig. 4.1.3.1 c. Fl uorescence spectra obta ined by successive add i t ions of 200 600 1 000)..t l  
port ions o f  1 0  )lg/m l ct-DNA to 1 .0 m l  o f  1 0  )..tg/m l r ifampic in  i n  phosphate buffer pH 6. 
The spectra were measured at 235 nm as A.max of exc i tat ion i n  ( I ) and at 3 3 5  nm as A.max 
of e c i tat ion in ( J 1  ) .  
Fig. 4.1.3.1d. F luorescence spectra obta ined by successive addi t ions of 200, 600, 1 000 )ll 
port ions of 5 0  )..tg/m l ct-DNA to 1 .0 m l  of 50 )lg/m l ri fampic in  in phosphate buffer pH 4 .  
The pectra were measured a t  235  nm as  "'max of exc itat ion i n  ( I ) and a t  335  nm as  Amax 
of e c itation in ( I I  ) .  
F i g .  4.1.3.1 e .  F luorescence spectra obta ined by successive add i t ions of  200, 600, 1000 )l l  
portions of 5 0  )..tg/m l ct-DNA to  1 .0 m l  of 50 )..tg/m l ri fampic in  in  phosphate buffer pH 5 .  
The spectra were measured a t  235  nm as "'ma. of exc itat ion i n  ( I ) and at 3 3 5  nm as "'max 
of exc itation in ( 1 1  ) . 
Fig. 4.1.3.1f. F luorescence spectra obta ined by success ive addit ions of 200, 600, 1 000 )ll 
port ions of  50 )lg/m l ct-DNA to 1 .0 ml of 50 )lg/m l ri fampic i n  i n  phosphate buffer p H  6 .  
The spectra were measured at  235  nm as A.ma of exc itat ion i n  ( I ) and at  335 nm as Amax 
of exc i tat ion in ( I I  ) .  
Fig.  4.1.3.1g. E ffect of pH on fl uorescence intensity of 1 0  )lg/m l ri fampic in at 465 and 
670 nm emiss ion "'ma measured at  235 nm as Amax and 3 3 5  nm as Amal( of exc i tations i n  ( 1 )  
and ( I I ), respect ive ly .  
Fig.  4.1.3.1h. Effect of pH on fluorescence intens i ty of 50  )lg/m l r ifampic in at 465 and 
670 nm em iss ion "'ma measured at  235 nm as "'max and 335 nm as "'max of exc itations in  (J) 
and ( I I ), respect ive ly .  
Fig. 4.1.3.4a. Ca l ibration curves of ct-DNA uS ing 5 ,  1 0, 1 5 , 20, 30  and 50 ppm 
R i fampic in  at 475 nm and pH 7. 
Fig. 4.1.3.4b. Cal i brat ion curves of  ct-DNA uSing 5 ,  1 0, 1 5 , 20, 30  and 50 ppm 
R i fampic in at 670 nm and pH 7. 
Fig. 4.1.3.6a. Bind i ng curves for ct-DNA with 5 ppm R i fampic in  at 475 nm (1) and 670 
nm in  ( 1 1 ). Plotted curves are based on equat ion. 
F ig. 4.1.3.6b. Bind ing curves for ct-DNA with 1 0  ppm R i fampic in  at 475 nm ( 1 )  and 670 
nm in (1J). Plotted curves are based on equation 2 .  
Fig. 4.1.3.6c. B inding curves for ct-DNA with 1 5  ppm R i fampic in  a t  475  nm ( 1 )  and 670 
nm in ( I J ) .  P lotted curves are based on equat ion 2 .  
Fig. 4.1.3.6d. B ind ing curves for ct-DNA wi th  30 ppm R i fampic in  at 475  nm ( 1 )  and  670 
nm in (IJ). Plotted curves are based on equation 2. 
Fig. 4.1.3.6e. B inding curves for ct-DNA with 20 ppm R i fampic in  at 475 nm ( 1 )  and 670 
nm in ( l J ) .  P lotted cur es are based on equation 2 .  
Fig. 4.1.3.6f. B inding curves for ct-DNA with 50 ppm R i fampic in at 475 n m  (1) and 670 
nm in ( J J ) .  Plotted curves are based on equation 2 .  
Fig. 4.2.1a. F luorescence spectra obta ined by success ive add i t ions of 1 0  /-11 portions of C5 
(20 Ilg/m l )  to 1 .0 m l  of A BTS (20 Ilglm l )  in phosphate buffer pH 7. 230, 340 and 390 nm 
were used as excitat ion wave lengths for the emission bands of 465 nm in  ( I ), 680 nm in  ( 
" ), and 780 nm in ( J J J  ) .  
Fig. 4.2.1 b .  F luorescence spectra obta ined by success ive add i t ions  of 10  /-1 1  port ions ofC6 
(20 /-1g1m l )  to 1 .0 m l  of A BTS (20 /-1g1 m l )  in phosphate bu ffer pH 7 .  230, 340 and 390 nm 
were used as exc itat ion wave lengths for the emission bands of 465 nm in ( I ), 680 nm in ( 
II ), and 780 nm in ( III ) .  
Fig. 4.2.1c. F luorescence spectra obtai ned by successive add i t ions of 1 0  /-11 port ions of 
C5-C6 dsD A (20 )lg/m l )  to J .O ml  of A BTS (20 )lg/m l) in  phosphate buffer pH 7 .  230, 
340 and 390 nm were used as exc i tation wave lengths  for the em ission bands of 465 nm in 
( I ), 680 nm in  ( II ), and 780 nm in ( III ) .  
Fig. 4.2.1 d. F luorescence spectra obtai ned by su cessive add it ions of 10 III port ions of ct­
D (20 Ilglm l )  to 1 .0 ml of ABT (20 Ilg/m l )  in  phosphate buffer pH 7 .  230  340 and 
390 nm were used as excitat ion wave lengths for the em iss ion bands of 465 nm in ( I ) , 
680 nm in  ( I I  ), and 780 nm in ( IJJ ) .  
Fig. 4.2. 1e. F luorescence spectra obta ined by successive add i t ions of 1 0  II I port ions of 
human DNA (20 Ilg/m l )  to 1 . 0 ml of A BTS (20 Ilg/m l )  in  phosphate buffer pH 7 .  230, 
340 and 3 90 nm were used as exc i tat ion wavelengths for the emission bands of 465 nm i n  
( I ). 680  nm in ( I I ) and  780  nm in ( I I I  ) .  
F i g  . .t.2.2.3a .  Cal ibrat ion curves of ssDNA (C5 ' C6) and dsDNA (C5 -C6) us ing 20.0 ppm 
ABT at 465 n m .  
Fig. 4.2.2.3b. Cal ibrat ion curves o f  ssDNA (C5 , C6) dsDNA (CyC6) and ct-DNA using 
20.0 ppm A BTS at 680 n m .  
F ig. 4.2.2.3c. Cal ibrat ion curves o f  ssDNA (C5, C6), dsDNA (C5-C6) and ct-DNA using 
20.0 ppm A BTS at 780 nm .  
Fig. 4.2.2.4a . Bind ing curves for synthetic ssDNA (C5) w i th  ABTS a t  465  in  (I) 680  nm 
i n  (II) and 780  nm in (Ill). Plotted curves are based on  equat ion 2 .  
Fig.  4.2.2.4b. Binding curves for synthet ic  ssDNA (C6) w i t h  A BTS (20  ppm) a t  465  i n  
(I), 680 nm in (I I ), and 780  nm in  (I I I). Plotted curves are based on  equat ion 2 .  
Fig. 4. 2.2.4c.  B ind ing curves for synthet ic  dsDNA (C5 -C6) w i t h  A BTS (20  ppm) a t  465 
in (I), 680 nm in (II), and 780 nm in (III). Plotted curves are based on equat ion 2 .  
Fig. 4.2.2.4d. Bind ing curves for synthet ic ct-DNA wi th  A BTS (20 ppm) at 465 i n  0), 
680 nm in (II), and 780 nm in (lIl). Plotted curves are based on equat ion 2 .  
Fig. 4.2.2.5.  F luorescence spectra obtained b y  add ing 2 0 0  II I of 1 0.7 M CUS04 i n  
phosphate buffer pH 7 t o  a m ixture of 1 .0 m l  ( 2 0  Ilglm l )  ct-DNA and 1 .0 m l  ( 2 0  Ilglm l)  
ABTS. Spectra were measured at exc i tat ion wave lengths of 235 nm in (1) 335 nm in  465 
in (II) and 390 nm (I I I ). 
Fig. 4.2.2.6. F luorescence spectra obta ined by adding 200 II I  of 1 0-7 M gJycene in 
phosphate bu ffer pH 7 to a mixture of 1 . 0 m l  (20 Ilg/m l)  ct-DNA and 1 .0 m l  (20 Il g/m l )  
BT _ pectra were measured at e c itation wavelengths of 2 3 5  nm i n  ( I )  3 3 5  nm in 465 
in ( I I )  and 390 nm ( I I I ) .  
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hapter 1 Inrroduction and Literature Survey 
1. INTRODUCTION 
uc\eic  acids dominate modern molecular cience .  They store and transmit genetic 
information \ i thjn cel ls .  In 1 953 ,  Watson and Crick described the structure of DNA and 
the role of the DNA molecule in holding the information for cel l  reproduction and 
function [ 1 ] . Over the l ast 60 years a lot of stud ies were conducted in order to reveal the 
basic and necessary background about different mechanisms that happens in our body 
regarding synthesis of proteins, d igestion of foods, rejecting of wastes fighting of 
d iseases . . .  etc . DNA and RNA as the basic heredi ty material in al l types of different cel ls 
were thoroughly investigated . Different tools, equipments, methods have been used to 
stud d ifferent types of interaction between nuc leic acids and d i fferent l igands. 
1.1. DNA Stru c t u res 
Deo yribonucle ic  ac id (DNA) is the "polymer of li fe". DNA is composed of units 
of purine and pyr imid ine bases attached to a backbone of a 5 -carbon sugar (dexoyribose) 
al ternating with a phosphate group. The purine bases-adenine (A) and guanine (G), and 
pyrimidine bases-thymine (T) and cytosine (C) are paired together A to T and G to C to 
al low repl icat ion of the DNA code (Fig .  1 . 1  a) .  The bases are made up of nitrogen and 
carbon atoms arranged in planar ring structures (Fig.  1 . ] b). DNA is  typical ly double 
stranded in a "spi ral staircase" structure with the pai red bases forming the "steps" (Fig. 
1 .2) .  
DNA can be found in three principal forms:  A, B,  and Z (Fig .  1 . 3 )  [2] .  The A form 
occurs under anhydrous condit ions «75% relative humidity) and is found in bacterial 
spores. The A form has 1 1  basepai rs per helical turn, a hel ical rise per basepair of 0.26 
nm, and a diameter of 2.6 nm . The B form i s  the most common form found under natural 
condit ions. It has 1 0  basepai rs per helical tum, a hel ical rise per basepair of 0 .34 nm , and 
a diameter of 2 .0  run. Both the A and B forms are right-handed hel ices, however, the Z 
form is a left handed helix and is bel i eved to serve as a genetic switch. The Z form has 1 2  
basepairs per hel i cal turn, a hel i cal rise per basepair of 0 .37 nm, and a d iameter of 1 . 8 
nm . 
Nucleic acids are very long, thread- l ike polymers, made up of a l inear array of 
monomers cal led nuc leotides. All nucleotides are constnlcted from a nitrogen 
2 
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heterocycl ic base, a pentose sugar, and a phosphate residue. The major bases are 
monocyc 1ic pyrimidines or bicycl ic  purines. 
ingle crystal X-ray crystallographic studies ha e shown that DNA can have over 
1 00 di fferent structures that have been provided the detai ls  on which standard DNA 
structures are now based [ 3 ] .  The fol lowing shows the average hel ix parameters for the 
major D A conformations [4] . 




teNH eNH NAo NAo 
H H H 
Cytosine T Thymine T Uracil U 
Pyrimidines 
Fig. l . I .  Structures of  the major pyrimidines and purines [ 5 ]  
Table. ] . l .  Average hel i x  parameters for the major DNA conformations. 
Structure type A-DNA B-DNA Z-DNA 
Helix sense R R L 
Residue per tum I I 1 0  1 2  
Twist per bp n° 32 .7  36 -9, -5 I 
Displacement bp Da 4 .5  -0 .2  - 1 . 8 - 2 to 3 
R ise per bpi A 0 29 3 . 3 -3 .4 3 . 7  
Base t i l t  .0 20 -6 -7 
M inor I 1 .0 5 .7 2 .6 
Groove width/ A 0 
Major 2 . 7  1 1 . 7 8 .8  
M inor 2 .8  7 .5  1 3 .8 
Groove depth/ A 0 
Major 1 3 . 5  8 .8  3 .7  
Helix sense as the left or right rotation o f  the DNA. Residue per tum a s  the number o f  the base-pair i n  each tum. The 
average rise Da and helix rotation 0 per base·pair define the pitch of the helix. The sideways tilting of the base-pairs 
through a tilt angle T pennits the separation of the bases along the helix axis Da. 
3 
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Adenine Guanine G 
Th)minc T 
Fig. 1 .2 .  tructmal representations of deoxyribonucleic acid (DNA) a) backbone and 
basepair . b) chemical structure of pmine and pyrimidine bases: (A) adenine, (0) 
guanine. (T) thymine. and (C) cytosine. 
Fig. 1 . 3 .  Depiction of double stranded DNA as a spiral staircase with phosphate and 
ugar backbones represented by orange banisters and basepairs represented by blue stair 
teps (pdb 88 A) [6, 7]. 
4 
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A-fonn B-form Z-form 
Fig .  1 .4 .  tructural models of the three forms of DN A .  
A major and minor groove traversing the spiral  structure are formed by the DNA 
backbone (Fig .  I.Sa). The major and minor groove d iffer not only in size, but a l o in 
polarity and chemistry [8] . The properties present in  the grooves are specific to the 
basepai rs which can lead to sequence spec ific binding in the grooves. In the major groove 
-T has a sequence of acceptor-donor-acceptor and G-C has a sequence of acceptor­
acceptor-donor (Figure 1 .5b) .  The major groove has more binding s i tes and exhibits 
directional i ty (e.g. AT vs. TA ) .  
5 
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D A i s  a polyanion which attracts posit ively-charged counter ions such as calc ium 
and magnesium ions in  buffer solutions to shield the electrostatic  charges. DNA i s  a 
fairly sti ff molecule with a persistence length of about 50 nm. Accord ing to the I UPAC 
Compend ium of Macromolecu lar Nomenclature, persistence length is  "the average 
project ion of the end-to-end vector on the tangent to the chain contour at a chain end in 
the limit  of i nfinite chain length" [9] .  DNA can be treated mathematically using the 
worm-like chain (WLC) model [ 5 ) .  
D A serves two central roles. F irst, i t  maintains the genetic  information and i s  
replicated to pass this information to each new cell . Second, i t  contains the code which i s  
translated into RNA which i s  then transcribed into proteins (Fig.  1 .6) . This  has become 
known as the central dogma of molecular biology. 
6 





Fig. 1 .5 .  Major and m mor grooves formed by D A hel i x- a)  relative groo e size 
illustrated with space-fill ing model, b )  chemical structure of base-pairs extendi ng into 
groO\ es 
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Fig. 1 .6. The "Centra l  Dogma of Molecular Biology" depicting the key cel lu lar processes 
of DNA repl ication and translat ion ( Access Excel l ence at National Health Museum) [3 ] .  
1 . 2 .  D A a n d  Drug I n te ract i o n s  
Anti -cancer therapies often target the DNA to  inhibit  the rapid repl ication of cancer 
cel ls .  Many di seases such as diabetes, Lupus, hemophi l ia, H untington's di sease, and 
Alzheimer's di sease may be traced to over- or under-production of proteins or production 
of mutated proteins.  DNA is the genet ic material that codes for proteins; therefore, drug 
mteractions with D A which can affect this process are potential treatments for these 
types of di seases. The mode of action of some drugs for the treatment of cancer, genetic 
8 
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disorders and v i ral d i seases i s  thought to be based on thei r  bind ing to DNA and their 
mod ification of DNA act iv i ty .  The act ivi ty of the drug is  often linked to the binding 
geometry. Thus the potential act ivi ty of a drug could be assessed by detect ing the DNA 
binding site and fit of the drug candidate. An analyti cal technique to elucidate the mode 
of DNAIdrug interact ion could be important for the design of advanced drugs. 
1.3. A n a lytica l Tec h n i q u es 
Currently, drug developers assess the interactions of drugs with DNA through 
indirect as ays, computer modeling, and clin ical trials. These methods do not provide the 
insight requi red to rati onally design or screen the compounds. Most clinical drug design 
and screening methods deduce the effects of compounds based upon the biological 
products produced downstream in the process, such as amino acids and proteins .  Atomic 
Force Microscopy (AFM) is  the only method of d irectly observing interactions of 
compounds with ind iv idual DNA molecules without stains and under natural condi tions 
with s imple sample preparati on.  X-ray crystallography, Nuclear Magnetic Resonance 
(NMR), absorption spectroscopy, gel electrophoresis, and Scanning Electron M icroscopy 
(SEM) are some of the other analytical techn iques that have been used in attempts to 
investigate drug i nteractions with DNA and the result ing DNA conformations; each has 
d istinct advantages and d isadvantages. X-ray crystallography records and analyzes the 
d iffract ion pattern of X-rays focused on s ize to determ ine the molecular structures of the 
substance that compri ses the crystal. This method is highly sensi t ive to extremely small 
changes i n  structure and the pos i tion of atoms and molecules i n  relat ion to one another. I t  
requires that the material can be h ighly concentrated into a nearly defect free, size form. 
The molecular conformation in  the crystal may be significantly d ifferent from the 
conformation in solut ion .  The preparat ion of the pure crystal sample is challenging and 
requires hours, days, or weeks of effort . The information about bound compounds is  
gathered statist ically from the numerous molecules i n  the sample, but  i s  highly accurate. 
Nuclear M agnetic Resonance (NM R) spectroscopy uses radiation to i nduce nuclear 
spin state changes which are unique for d ifferent atoms and thei r  local environment. 
From the spectrum acqu ired on solid or liquid samples, the structure of molecules can be 
deduced . NMR can observe static as well as dynamic  i nteract ions between molecules .  It 
9 
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requires that the sample be d issolved in a deuterated solvent and averages the results from 
all the molecules in the sample. The spectrum requires sign i ficant expertise to interpret 
and , depending on their complexity, may not be definit ive. 
Circular d ichroism (CD) spectroscopy and UV -vis spectroscopy provide structural 
information on molecules based on their absorption of d ifferent wavelengths of light. CD 
spectroscopy measures the absorption of left and right handed c i rcularly-polarized light 
which d i fferent iates based on the molecules chirality and secondary structure. UV -vis 
spectroscopy uses the wavelengths of light in the spectrum ranges of 200 to 800 nm. 
D A typically absorbs in  the region of 260 to 280 nm due to the electronic transit ions 
regions of the bases. These techniques are conducted in solution and are s imple to 
conduct but average the results across molecules in  d ifferent states. 
Gel electrophoresis separates DNA fragments into bands relat ing to their 
characteri stics (e .g .  length, conformation charge) which can be compared to standards to 
draw conclusions about the sample. It also is fai rly quick and easy to conduct, but has the 
same d isadvantages of averagi ng the results of numerous molecules in a sample instead 
of looking at interactions with an individual molecule and requiring interpretation of the 
interactions from i nd i rect evidence. 
Electron m icroscopy can d irectly image individual molecules; however, stains or 
contrast agents are required which reduce resolution. E lectron m icroscopy i s  typically 
done under vacuum; molecular conformation in vacuo often d iffer from those found i n  
natural envi ronments. 
Atomic Force Microscopy (AFM) can di rectly image individual molecules without 
stains in l iquid, gaseous, or vacuum environments. It can measure the three-dimensional 
surface profile, as opposed to just providing a two-dimensional image. The main 
di sadvantages of AFM are i ts limi ted image size, inabi l i ty to detect chemical bonds, and 
requirement that sample molecules are securely immobilized on a solid surface. 
Optical tweezers force spectroscopy, a method related to AFM, has recently been 
employed to study the effect of drug binding on DNA lengthening and elasticity and 
related these properties to the mode of drug binding [4 ] .  
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1 .4 .  B i n d i n g  M od e  
Most drug binding to DNA does not involve covalent bond formation and, 
therefore, i s  an equili brium process. The bind ing constant can be determined by 
measuring the free and bound forms of the drug. The thermodynamics are c lassically 
dri en by electrostati c  attractions, hydrophobic interactions, hydrogen bonding, and van 
de Waals forces [ J  0 ] .  
There are two key modes of  noncovalent drug interactions with the DNA helix­
groo e binding and i ntercalation (Fig.  1 .6), as well as combinat ions of these modes and 
nonspecific b inding. Polyamines, such as spermid ine and spermine, are considered to be 
nonspecific b inders with primary interactions being electrostat i c  b ind ing to the anionic 
phosphate backbone (Fig .  1 . 7). Cyanine dyes are known to exhibit a combinat ion of the 
binding modes [ 1 1 ] . 
a b c 
Fig. 1 . 7 .  Models of drug and DNA interactions- a) intercalat ion, b) major groove 
binding, and c) m inor groove binding. 
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1 .5. ,-oove Binder  
�l inor groove b ind ing drugs are typical ly th in  and crescent shaped to sterical ly fit  
into the narro"" minor groove. Examples of minor groo e binding l igands include 
<.i Istamyc 1 l1 ,  netr p t J) ,  Hoechst 33258, and chromomyc in ( Figure 1 . 8 ) .  They do not 
change the gross tructure of D A; however, X-ray crystal lography has shown that 
netrop in caused sma l l  d istort ions in  widening the groove and causing a s l ight bend in the 
double heli [ 1 2 ] .  tudies have also detected that monovalent cations bind in tbe minor 
groO\ c and produce bend ing [ 1 3 ] .  
Fig. 1 .8. tructural model s  o f  spermi ne binding to the phosphate backbone o f  DNA at 
two di fferent viewing angles based on X-ray d iffraction at 1 . 9 A resol ution (pbd I OOD) 
[ 7 . 1 4] .  
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There are re\\ er major groo e binding drugs, al though t lL i s  i s  a very common 
b1 l1d lng mode [or prot ins to regulate gene expression. E amples of  major groove 
binding urugs I J1c l ude c i sp lat in ,  a lkylators, and mustards (Fig .  1 .9 ) .  
Fig. 1 . 9 .  tructuraI model of  dystamycin  b ind ing t o  the m i nor groove of  D A based 011 
X-ray d lffraction at 1 . 8 5  reso l ution (pdb l JTL) [7 , 1 5 ] 
1 .6 .  I n tercalators 
Intercalat ion occurs when a p lanar aromat ic  structure I S  insel1ed bet\: een the 
Watso11- Crick basepairs which causes the DNA basepairs to separate and the overal l  
strand to lengthen and sl ightly unwind.  Compounds with two or three fused lings do not 
completely fi l l  the space between the basepairs whi l e  four fused rings correspond in size 
to stack effic iently with the basepairs [ 1 6] .  lntercalators general ly have a preferent ial 
binding between 5 '  pyrim idine-purine 3 '  steps [ 1 7] .  Exampl es of intercalators inc lude 
ethidlUlll, daunomycin ,  echinomyc in ,  actinomycin ,  and quinacrine (F igure 1 . 1 1 a ) .  Drugs 
and smal l  molecules that i ntercalate with DNA are considered to be effect ive inten'upters 
of D A rep l icat ion, transcription, and repair processes. 
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Fig. 1 . 1 0 . tructural  model of  phenazine binding to the major groove of DNA based on 
X-ray d i ffraction at 2 .00 A reso lution (pdb l EG6) [ 1 8] 
Poly- intercalators are a c lass of intercalators in  which mu lt ip le intercalating units 
are jo ined together with a l inker compound. The chemical moiet ies physical length, and 
rotat ional r igidity of l i nker compound have an important influence on the binding affin ity 
and select iv i ty of the intercalator [ 1 7 , 1 9] .  I t  has been shown that regional charge 
densit ies impact the stacking stab i l i ty and structure [20] . In add it ion, di stort ion of  the 
D A occurs  with some bis- intercalators the degree of which is dependent on the l i nker 
structure [2 1 ] . D itercal in ium,  th iazole  orange dimer (TOTO), ethidum acridine, and 
flexid i  are examples of bis-intercalators (Figure 1 . 1 1 b) that have been shown to cause 
twice the D A hel ical  extension and unwinding of a mono-intercalator. Tradit ional ly, the 
detection of intercalat ion has been based on a spectrophotometric shi ft which requi res 
that the intercalat ing moiet ies are chromophores. Another indirect method of inferring 
Illtercalation has been based on the i ncrease in DNA double  he l ix  stabi l i ty. resul ting in 
decreased heat denaturat ion .  DNA intercalat ion can be definit ively determined based on 
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traml lengthen ing whIch is  b st mea ured by AFM [22] . Gel electrophoresis and 
\ I cOlllctry studies rely on D lengthening to deduce intercalation, but can be 
omphcat d b other factors. M R  images of l igands intercalated with D A have been 
acq lll reU which help estab l i sh the structural position of the l i gand binding. 
b 
Fig. 1 . 1 1 t ructural models o f  D A with a) daunomyc in mono- intercalation based on X­
ray d i ffract ion at 1 . 50 A resolut ion (pdb I DAO) [7 , 23 ]  and, b) th iazole  orange dimer bis­
intercalat ion based on 40 NMR structures (pdb 1 08D)  [7 ,  24] . 
1 .7 .  C l i n ica l  A p p l ic a t i o n s  
Drugs that i nteract with D A have c l inical s ign i ficance for the  treatment of so l id 
tumors. lymphoma, and leukemia. The interruption of  DNA repl ication is effect ive 
agamst rapidly reproducing cancer cel ls .  More efficient and targeted DNA-binding drugs 
can be achi\'ed by desiging new compounds with mu l tip le b inding moiet ies that bind to 
spec i fic D A sequences. 
1 .8 .  Poly- ' a p h t h a l en etetraca rboxyl ic D i i m ide 
A unique series o f  poly-intercalators has been designed in  Brent Iverson's  lab at 
niversity of  Texas, Austin based on aedamer stacking studi es. The series i s  composed 
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of 1 ,4 5 8-naphthaJenetetracarboxylic d i imide (ND!) aromatic  groups l i nked by four 
amino acid  segments (Figure 1 . 1 2) [25 ) .  It includes bis- ,  tris-, and tetra- intercalators with 
enhanced b ind ing affini ties and was eventually extended to produce the first 
octakis intercalator [26] .  The N DI units were strung together i n  a head-to-ta i l  fashion with 
variable l inker polypeptide sequences. The synthesis  of the molecules was accompli shed 
using standard 9-fluorenylmethyoxycarbonyl (Fmoc)-based solid-phase methods. A 360-
member library of d ifferent linker sequences was produced using combinatorial methods 
[27) . 
L ike their aedamer predecessors, the poly-NDI molecules are in i t ially stacked in  
solution. The stacking arrangement i s  i dent ified by the upfie ld shi ft  of the d i im ide 
hydrogen in MR and the rate-lim it ing slow unstacking step of the association constant. 
Howe er, the addi tion of 2% SDS releases the stacking conformation as revealed by the 
absorption spectrum max imum returning to that of the monomer measured by UV -vis 
spectroscopy [25 ] .  Poly-NDI was designed to be a threading intercalator, although UV 
dissociat ion measurements of some of these compounds are not consistent with th is  




Fig. 1 . 1 2 Structure of 1 ,4 ,5 ,8-Naphthalenetetracarboxylic d i im ide (NDJ )  with pept i de 
linker where n = 1 for b is-NDI ,  n = 2 for tris-NDI ,  and n = 3 for tetra-ND I  
Threading i nvolves one side chain o f  the intercalator being located i n  the major groove 
whi le the next side chain is located in the m inor groove. This geometry requires that the 
intercalator "threads" through the DNA scaffold as shown in Fig .  1 . 1 3 . Other 
intercalators such as anthraquinone [29] ,  poly-NDI derivat ives [30] ,  and the related 
bis imide elinafide (LU-79553 )  [ 3 1 ]  were previously demonstrated to exhib i t  th is  
threading geometry .  Advantages of the threading mode stem from its obstruction of both 
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o . grom es, lmpro,' d equenc peci ficity and slower dissoc iation rates. Thi would 
11<1\ C I lnp l ication [or dmg efficacy to interrupt translation and repl ication processes. The 
pcc I fic  l i nker tructure of lysine and tri -glycine, has been invest i gated with UV-vis  
pectro cop , v iscometry, and 0 Ase footprinting to pre l iminari ly  detennine that 
l Il tcrcn iat lOn is the binding mode [15 ] . The compounds were found to have a higll binding 
a ffi n I t )  for double  stranded 0 , as wel l  as general spec i fic i ty for GC sequences. 
hnngll1g th l inker sequences resul ted in much stronger sequence spec ific i t ies al lowing 
,\ � l R  analy is  to resolve D A binding interactions (F igure 1 . 1 4) [ 32 ] .  Interest ingly, the 
rever al of  th p lacement of  the lysine after the tri -glyc ine, instead of  before i t ,  yielded 
one of the compounds with greater sequence spec i fic i ty. In addi tion the subst itution of 
<1lani l1 for lysine resul ted in the al teration of  the l i nker binding i n  the minor versus major 
groO\ e [2 ] .  
Fig. 1 . 1 3  Schematic o f  threading intercalator with ring moiety (pink) inserted between 
basepai rs and l i nker structures l ying in the minor (green) and major (b lue) grooves 
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b 
Fig. 1 . 1 4  NMR structures of bis-NDI compounds with l inker structures a) Alani ne­
Alanine-Alan ine-Lysine in the minor groove, and b) Glyci ne-Glycine- Glycine-Lysine i n  
the major groove [ 33 ] .  
Table 1 .2 List of DNA-interact ive drugs used c l i n icalJy o r  in clinical research trials (key 
ref. : http://gucfm .georgetown .edu/welchjj/netscut/heme onc/dnadrugli st . html) 
Drug Name Chem ica l N a m e  Mode of 
I n teraction 
ActinomycinD 3H-Phenoxazine- 1 ,9-dicarboxamide Intercalat ion 
Adolzelesin, 
Cyclopropylpyrroloindole Minor groove 
U-73 ,975 
Ametantrone 
1 ,4-bis[(2-2((2-hydroxyethyl) am ino )ethyl)am ino-
Interca lat ion 
9, I 0- anthracened ion� 
Amiloride, 3 ,5-diamino-6-chloro-N -(  d iam inomethylene) 
Interca lation 
Midamor pyarazi necarboxam i de 
B isantrene 
9, I O-anthracened icarboxaldehyde bis[( 4,5-dihydro-
Intercalation 
I H- imidazol-2y)hydrazone] 
Bizelesin, 
Cyclopropylpyrroloindole Minor groove 
U-77,779 
CC- I 065, U-563 1 4  Cyc lopropylpyrrolo-indole Minor groove 
Chromomycin A3 Aureloic ac id Minor groove 
CI -958, Parke-
Benzo( chalcogeno)[ 4,3,2 -cd] i ndazo I e Intercalation 
Davis 
8-acetyl- 1 O-[(3 -am i no-2,3,6-trideoxy-alpha-L-lyxo- Intercalat ion, 
Daunomycin, hexopyranosyl)oxy J-7 ,8,9, 1 0-tetrahydro-6,8, 1 1 - d i rected into 
Cerubidine trihydroxy- 1 -methoxy-,(8S-c is)-5, 1 2- m inor groove 
Naphthacened ione 
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Table  1 .2 :  cont. 
Drug Name Chemical  N a m e  Mode of 
I n teraction 
DAP I  4 '  ,6-d iamid ino-2-phenyl i ndole d i hydroch loride M i nor groove/ 
hydrate i nterca lat ion 
DACA N-f2-( d i methyl am ino )-ethyl ]acrid ine-4-carboxam ide I nterca lat ion 
Distamyc in  A, 3 - [  l -methyJ-4-[  I -methyl-4- (fonnylam ino)pyrro le-2-
M inor groove Sta l l imyc in  carboxam ido ] -propionamid i ne hydroc h loride 
N,N'- [2 ,4,  1 2 , 1 5 , 1 7 ,25 -hexamethyl- l l ,24-bis( ) -
Ech inomyc in  
methylethyl )-27-(methy l th io)-3,6 1 0, 1 3 , 1 6 , 1 9,23 26- B is-
octaoxo-9,22-d ioxa-28-th i a-2 5 , 1 2, 1 5 , 1 8 ,25- in terca l at ion 
hexaazabicyc lo [ 1 2 . )  2 . 3 ]  
Eth id ium bromide 
2 ,7-d iam i no- ) O-ethyl-9-phenylphenanthri d i n i um 
I nterca lat ion brom ide 
Hedam c in  H edamyc i n  I nterca lat ion,  
thread i ng 
Hoechst 3 3258  
2 (  4-hydroxyphenyl)-5 { 5- (  4-methy lp iperzi ne- ] -y l)-
Minor groove benzi m idazo l -2-yl]benzi m idazo le 
mAMSA (N - [4-(9-acrid iny lam i no)-3 - I nterca lat ion,  
amsacrme methoxyphenyl]methanesu lphon an i l ide threading 
[ I  aR-( J aa lpha,8beta,8aa lpha 8balpha)]-6-am i no-8-
[ [ (aminocarbonyl)oxy ]methy l ] - ] , I  a,2 ,8 ,8a,8b-
M inor/M aj or 
M itomyc in  C hexahydro-8a-methoxy-5-
methylaz iri no[2 ',3 ' : 3 ,4 ] pyrrolo[ ] ,2-a lpha ] indo le-4, 7 -
groove 
d ione 
Netrops in  T- 1 3 84 Netropsin  M inor groove 
ogalamyc in  oga lamyc in  
I nterca lat ion,  
threading 
o-AMSA 4 '  -(9-acrid i nylam i no )methanesu l fono-an i s id ide I nterca l at ion 
Ti lorone 2 ,7  -b i s [2- (  d iethy lamino )ethoxyl ] - fl uoren-9-one I nterca l at ion 
Tomamyc in  Pyrro lo-( l ,4 )-benzod iazepine M inor groove 
1 .9 .  Co ndensat ion 
D A condensat ion i s  defined as an increase i n  the volume compression rat io  which 
results in the fonnation of h igh ly-ordered structures. I t  i s  d i fferent iated from aggregation 
or prec ipitation based on the order and fin i te s ize of the structures. Condensation occurs 
natural l y  where rep l ication and transcription are not act i vely transpi ri ng, such as v i rus 
capsids and spenn cel l s  [ 34 ] .  The mechanism of fonnat ion of the unique condensate 
morphologies (F igure ] . 1 5) of toroids (doughnut- l i ke structures), spheres, and rods has 
been the focus of m uch research during the past 30 years, yet it remains e lus ive .  It is  
postulated that condensat ion occurs when 90% of the DNA negat ive charge from the 
phosphate backbone is neutra l ized [ 35 ] .  This electrostatic effect has not been found to be 
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sufficient to completely account for the condensation forces. K inetic and thermodynamic 
based models ith e lectrostat ic and hydrostat ic mechani sms have been proposed [36) . 
Polymer physic ists have used a "bead-spring" model of semi flexible polyelectrolytes [ 3 7] 
[0 study this phenomena as a "coi l-globule" transi t ion [38  39] ,  although DNA does not 
truly behave as a random coil to fit the model. 
While in vivo condensat ion is d i rected by proteins (such as h istones) identical 
structures are formed in vitro by a variety of compounds includ ing mult ivalent cations 
+J 
(CoCNH)6 . spermid ine, and polylysine), ethanol, and PEG. There are obvious energeti c  
barriers against the compaction of  the DNA molecule to  overcome entropy and 
electro tatic repuls ions and s ign i ficant energy is expended by organisms which i s  
estimated to  be  approxi mately one A TP hydrolyzation per two basepairs packaged [40] . 
I t  i s  surpris ing that condensat ion occurs spontaneously in vitro under fai rly broad 
condit ions with the above listed condensing agents . Currently, there is much i nterest i n  
the application o f  condensat ion for debvery o f  DNA i n  gene therapy to afford protect ion 
from nucleases and other enzymes during cel lular entry [4 1 ] . The folding of DNA during 
condensat ion bears some s imilari t ies to protein  fold ing which i s  also of strong interest 
with numerous applications. 
20 




Fig. 1 . 1 5  Classical DNA condensate morphologies of toroid,  sphere, and rod 
1 . 1 0. I n te raction of N u cleic  A cids w i th S m a l l  M ol ecu les 
The unique complementary structure of DNA between the base pai rs AfT and C/G 
has been the bas is  for genet ic  analysis over the last few decades. The abi l i ty of a single 
stranded DNA (ssDNA) molecule to seek out or hybrid ize its complementary strand in a 
sample is the foundation of  DNA based detection systems.  Analysis based on binding to 
target molecules such as organic dyes, amino acids, v i tamin B 1 2 , biological cofactors, 
antibodies and drugs has been reported [42 ] .  
The organized centers of charges i n  DNA or  RNA,  N-donor bases, grooves, 
cavities, l oops and geometry of these molecules can selectively bind or preferential ly 
encapsulate some organic  and inorganic  species [43-44 ] .  These features make RNA and 
DNA unique l i gands with a combination of selectiv i ty and chemical recognit ion, which 
offer a novel entry into the field of select ive binding [45 ] .  Due to d i fferent mode of 
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binding of ligand or speci es reversibly to the nucleic acids especially DNA, its worthy to 
mention d ifferent or possible binding mode to double helical nuc leic acids .  
First nucle ic acids interact reversibly with a broad range of chemical species that 
include water, metal ions and the i r  complexes, small organic  molecules, and proteins 
[45] .  The importance of reversible i nteractions lies on dramatic structural transit ions in  
nuc leic acids are brought about by changes in  water act iv i ty, salt concentration (ionic 
strength), or by i nteraction with organic  molecules. Second, one of the most i mportant 
line of drug development and of current chemotherapy against some cancers, v iral, and 
parasit ic d iseases involves drugs which i nteract reversibly with nucleic acids .  Third, 
because of their relat ive s implic i ty,  the i nteractions of small molecules with nucleic acids 
have pro ided much of our most accurate information about nucle ic  acid b inding 
spec ificity [46] . 
Molecules and ions interact with nucleic acids in  three primary ways ( 1  )-Binding 
along the exterior of the helix through interactions, th is i s  generally non-specific  and are 
primari ly electrostat i c  i n  orig in .  (2)-Groove-binding interactions, involve d i rect 
interactions of the bound molecule with the edges of base pairs in ei ther of the major or 
minor grooves of nucleic acids .  (3)- Intercalat ion of planar or approximately p laner 
aromatic  ring system between base-pairs [47] . 
The fi rst two binding modes do not requ i re nucle ic ac ids conformational changes, 
but may i nduce structural transi t ions on complex formation. Intercalation requ i res 
changes in sugar-phosphate chain torsional angles for separat i on of adjacent base pairs by 
a d i stance (typically near 3 .4 A 0) sufficient to allow insert ion of the intercalating ring 
system. Thi s  can be accompanied by other changes in  the helical parameters such as 
unwinding. bend ing, and other parameters. [47] . 
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1 . 1 1 .  D A Ba ed Biosensor 
A bio ensor i s  an analyt ical device that combines the specifici ty of biological 
sensing element with a transducer to produce a s ignal proport ional to target analyte 
concentrat ion. This signal can result from a change in proton concentrat ion, release or 
uptake of gases such as ammonia or oxygen light emission absorpt ion or reflectance, 
heat emission, mass change, etc . The s ignal is converted by a transducer i nto a 
measurable response such as current, potential, temperature change absorption of light, 
or mass increase through electrochemical, thermal, optical means [48] . 
The unique complementary structure of DNA between the pai rs adenine/thymine 
and cytosine/guanine has been the bas is  for genetic analysis .  The ability of a single 
stranded D A ( ssDNA) molecule to seek out or hybrid ize to its complementary strand in  
a sanlple i s  the foundation of DNA-based detection systems [48] .  
1 . 1 1 . 1 .  Principles of DNA B i osensors 
The D A techn iques i ncluding hybrid izat ion, amplification, and recombination, 
are all based on the double helix structure of the DNA. Nucleic acid hybrid ization is the 
underl ing principle of DNA biosensors [49] . The single stranded DNA (ssDNA) is  
relat ively stable, but  at  low pH, the DNA molecule reforms or reanneals i nto the double 
stranded configuration. Reannealing between the ssDNAs from d i fferent sources i s  called 
hybridizat ion. The reannealing of the dsDNA is possible because nucleotide bases will 
reform hydrogen bonds only with spec ific complementary bases :  adenine pairs with 
thymine and cytosi ne pairs with guanine.  The stabil i ty of the hybrid ization depends on 
the nucleotide sequences of both strands. A perfect match in the sequence of nucleotides 
produces very stable dsDNA, whereas one or more base mismatches impart i ncreasing 
instabili ty that can lead to weak hybrid izat ion of strands [49] . 
Like other b iosensors, DNA sensors are usually in  the form of electrodes, chips, 
and crystals; hence, hybri d ization on a sensory surface is  a solid-phase reaction. Solution 
hybrid ization is more rapid  than hybrid izati on on solid-supports, but unless the assay is a 
homogeneous assay, a separation step i s  requi red before final detection [ 50-5 1 ] . Solid 
phase or filter hybrid ization is the longest established and the most often used [ 52 ] .  
2 3  
Chapter J Introduction and Literature Survey 
The kinetics and mechanism of nucleic acid single strand hybridization have been 
widely studied in solution [ 53 ) .  Hybrid ization in solution is bel ieved to be a two-steps 
proce in o lv ing nucleat ion and zippering up. Nucleation is the rate- l imi t ing step, and a 
second order reaction equation can describe the process. The nature of the hybrid ization 
reaction on sol id surfaces has been assumed to approx imate c losely to that of 
h bridization in solution. However, the rate of sol id-phase hybrid ization is only about a 
tenth to a hundredth of that in  solution [54 ] .  Al though not systematical ly examined, i t  has 
been suggested that efficient hybridization to DNA attached to sol id  supports can be 
impeded b several related phenomena. For example, the immobi l ized DNA molecules 
may l i nk to sol id surface at several points along the DNA chain;  hence some of the 
attached D A may not be accessible for hybridization [ 5 5 ] .  
1.11.2. Optical  D N A  B iosensors 
Several k inds of optical  DNA biosensors were reported [ 56-5 7 ] .  The fluorescent 
D A stain eth id ium bromide (EtBr) (F igure. 1 .  1 6) has been l argely used for the detection 
of D A [ 5 8-59] .  The fluorescent ethid ium cation strongly associates with dsDNA by 
intercalat ion into the base-stacking region and the maj or groove of the double hel i cal 
structure [59] . EtBr has an absorption max imum of 5 1 0  nrn ;  exposing i t  to an EtBr 
solution, washing off the unbound EtBr and measuring the fluorescence intensity by UV­
visible spectroscopy achieve detection of dsDN A .  The fluorescence intensity is  directly 
proportional to the amount of EtBr-intercalated DNA. Biosensors can be designed to use 
this princip le .  
Il, 
Fig. 1 . 1 6. The Structure of Eth idium Bromide (EtBr) .  
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It was reported that EtBr and other fluorescent compounds l i ke acridine orange 
(AO) and methylene blue M B  are often used to probe DNA structure in drug-DNA and 
protei n interact ions [60 ] .  They can bind to nucleic acids via intercalat ive mode and cause 
major changes to DNA and RNA structures. 
Although EtBr i s  often used for visible detect ion of DNA, under ideal condit ions i t  
has a sensi t iv i ty of  5 to 50 ng DNA that is not part icularly h igh compared with 
polymerase chain reaction ( PCR) or nucleic acid hybrid ization assays. At the same t ime, 
EB is notoriously harmful .  So far no effect ive replacement for EB is avai lable, but 
promising substances are under i nvest igat ion [60] . 
Fluorescent probes covalently immobi l ized directly into i mmobi l i zed ssDNA and 
had high quantum yie lds when in tercalated into the base-stacking region of dsDNA. The 
tethered fluorescent probe provide a reduction in the response t ime, be unaffected by non-
pecific absorption, and offer greater portabi l ity because of the reduced demand for 
external solution treatment. Washing with hot chaotropic salt solutions is also being 
investigated for remov ing cDNA strands from the surface of the fi ber. Chaotropic salts 
decrease duplex stabi l i ty and improve the regenerabi l i ty of the biosensors [ 56-60] .  
1 . 1 1 .3 Electroch e m i ca l  DNA Biosensors 
l i l l an et a 1 .  [ 6 1 ]  developed DNA sequence-se lective biosensor employing 
electrochemical transduction.  A DNA probe sequence was covalent ly bound to the 
surface of an Amperometric e lectrode [6 1 -62 ] .  Hybrid ization of the immobi l i zed probe 
sequence with i ts  d issolved complement produced an immobi l i zed double strand that 
could be detected using redox-active metallpolypryid ine complexes that associate 
selectively and revers ib ly with double-stranded DNA. The presence of the i mmobi l i zed 
double strand caused preconcentration of the metal complex in the DNA layer near the 
surface of the electrode, and it resul ted in much larger voltmmetric peak currents than the 
observed for immobi l i zed single-stranded DNA.  Studies with ox id ized glassy carbon 
electrodes have shown that ol igo and polydeoxynucleotide can be covalently immobi l i zed 
into carboxyl ic  acid groups using water-soluble carbod i imide and N-hydroxysuccin imide 
coupl ing reagents and that this reaction is select ive for immobi l i zat ion through 
deoxyguanosine residues [63 ] .  
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Apparently electrochemical transduct ion-based DNA sensors are easy to construct, 
needing only two electrodes and a voltammeter however, the sensi t iv i ty and specificity 
of such constructs i poor [63 ] .  
With the recent advent o f  DNA probe technology, a number o f  selective o l igomers 
that interact with the DNA of important biological species have been ident i fied. These 
have been used to provide a new type of selective biorecogni tion element which is h ighly 
selective, stable, and can be easi ly synthesized in  the laboratory as compared to other 
chemical ly  synthesized biorecognit ion elements, such as cata lyt ic ant ibod ies .  As a result, 
specific-spec ific  D A probes may now be exploited for biosensor development. It 
usual ly takes about 20 hours or more to finish a trad iti onal fi l ter hybrid izat ion procedure 
[52 ] .  Thus, DNA biosensing is often thought of as slow. However, great effort has gone 
i nto reducing the t ime of DNA hybrid izat ion. So far, many DNA biosensors could 
produce results wi thin an hour [56, 60-64, 6 1 ] . 
Nevertheless, a si mple. fast, and inexpensive DNA based biosensor suited to 
routine use sti l l  remains to be developed . Considering the h igh chemical stabi l i ty of DNA 
relat ive to other recognit ion elements such as enzymes, ant i bodies or other selective 
proteins, it i s  remain opt imist ic  about the near-term possibi l i ty of a truly rapid,  sensi t ive, 
easy to use and d isposable DNA biosensor [64 ] .  
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Zhenxin ,  et al have stud ied the temperature dependent i nteraction of neutral red 
(NR) with calf thymus ct-DNA using d ifferential pulse voltametry (DPV), UV-vis ible 
absorption c i rcular d ichorism (CD), and fluorescence spectroscopy [65 ] .  The results 
have shown that NR intercalates by insert ing completely in  the G-C base pairs and orient 
with its long ax i s  perpendicular to the dyad axis of DNA double hel ix .  On the other hand, 
at h igh concentration of NR to ct DNA, one part ia l ly i ntercalated NR molecule couples 
with a second external ly bound NR molecule to form an aggregating complex that stacks 
along the surface of the hel ix .  Changes in DPV curves of NR-ct DNA as wel l  as changes 
in �ax of absorpt ion upon temperature increase ind icating that interaction between NR-
ct D A was changed by temperature. The intensity of the fluorescence was decreased for 
ND-ct DNA by increasing the temperature indicating that binding mode of NR with DNA 
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is  changed . D spectra of t DNA at d ifferent temperature; increasing the concentration 
of R in ct D A solut ion the i ntensi t ies of CD spectrum were i ncreased, suggesting that 
ct D interact with NR and induces conformat ional changes and binding mode of NR 
with ct  DNA i s  influenced by h igh temperature [65 ] .  
Chun Xn, et a I ,  d i scussed an electrochemicaJ labeled DNA probe for detection of 
sequence spec ific  DNA [66] . A denatured cal f thymus ct-DNA was successful ly labeled 
with an electrochemical active reagent ferrocencarboxaldehyde (FCA) by l -ethyl-3-(3-
dimethyl -aminopropyl)  carbodi im ide (EDC). This FCA labeled DNA probe was used to 
hybridize with the sample D A sequence accumulated on the surface of a graphite 
electrode. Only the complementary sequence (c DNA) can form a double-stranded DNA 
with the FCA labeled DNA probe. The anodic  waves of the FCA bound to the double­
stranded D A by d i fferential pulse voltametry (DPY) are used for the detect ion of DNA.  
The anodic peak currents of FCA are related to the concentration of c DNA sequence 
between l .0 x 1 0-8 and 5 .0  x 1 0-6 mol r l .  The detect ion l imi t  was Sx 1 0-9 mol r l .  The 
probe showed high sens i t iv i ty and select iv i ty [66] . 
Quartz crystal resonator (QCR) was used to identify the mode of interact ions 
between smal l DNA-binding molecules and calf thymus ct-DNA according to the 
al teration of the v iscosi ty of the solut ion.  The results showed that compared to tradit ional 
viscosity measurement method, the use of QCR has the benefits of automation, t ime 
saving, h igh sensi t iv i ty and stab i l i ty ,  as wel l  as easy operation and cleanup [67] .  
The reaction of Fe ( I I I )  bleomyc in (Blm) was examined in  the absence and i n  the 
presence of calf thymus DNA, to investigate the effect of DNA binding on the properties 
of FeBlm activat ion and DNA strand c leavage. I t  was hypothesized that the metal 
domain- l inker of Fe( I I l )Blm adopts two conformations with respect to DNA. One, at 
specific binding s i tes, is relatively unreactive with ascorbate. The other, present at non­
speci fic s i tes as H P04-Fe( I I I )Blm, is  readi ly reactive with ascorbate to generate H02-
Fe(I I I )Blm-DNA. At the larger base pair to drug ratio, movement of Fe( I I l )Blm between 
speci fic and non-spec ific  sites to generate H02-Fe(I I I )Blm is a necessary part of the 
mechanism of strand scission [68] . 
Danke Xu, et al ;  developed a microfabricated electrochem ical d i sposable DNA 
sensors based on the immobi l i zation of DNA probes on photol i thographic gold fi lm 
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electrode by self-assembled monolyer technique.  The complementary sequence was 
hybridized to the mod ified electrode and the hybrid ization reaction was carried out at 
3 7°C for 1 hour. Avid in-alkal ine phosphate was coupled to the hybrid though avidin­
biot in complex and hydrolyzed to produce an electroactive alpha-naphthol, which could 
be detected by d i fferential pulse vol tametry (DPV). Numerous factors including the 
concentrat ion of the substrate and incubation time are opt imized to maximize the 
sensit ivity and speed in the assay time. The sensors were employed to detect PCR 
products re lative to the hepati t is  B plasmid .  The method has a l inear cal ibration curve 
range of 1 . 5 nmol/L- 50 nmollL and the detection l imit  was 30 fmol [69] .  
Yong-Mei Hao, e t  a l  has developed a new fluoremetri c method for nucleic acids 
determination based on the reaction of aluminum ( I l I )- sal i cy l idene-o-aminophenol 
complex with nucle ic acids  that resulted in  the decrease of fluorescence i ntensity of the 
alumin ium complex . The cal ibration graphs for calf thymus ct-DNA, fish sperm DNA 
and yeast RNA were l inear up to 5 . 0, 4 .0 and 3 .0 )lg mr ] respect ively, and corresponding 
detection l imi ts are 49, 52  and 62 ng m)" ' . The synthetic samples were analyzed with 
relative standard deviation of five measurements of 3 .9-6.0 %. DNA in an extraction 
product from human blood was determined using the cal i bration graph for ct DNA, and 
the result was very c lose to that by the eth id ium bromide assay. The association constant 
of ct DNA with the complex was estimated by two graphic methods. It was suggested 
that the binding react ion between nucleic acids with the complex proceeds in an 
i ntercalat ion way [ 70 ] .  
V .  Brabec employed a DNA sensor for the determination of ant i tumer platinum 
compounds [ 7 1 ] . A wax impregnated graphite electrode coated by l inerized plasmid 
DNA was employed as a sensi t ive biosensor for the detection of p lat inum compounds. 
The sensor rel i es on monitoring changes in the i ntrinsic e lectrooxidation response of the 
surface-confined DNA resul t ing from its interaction with platinum compounds and 
requires no l abel or indicator. The results of th is  work showed that platinum compounds, 
which readi ly  b ind to DNA in solutions, can a lso bind to this nucleic acid immobi l i zed at 
the e lectrical ly charged surface. In  addit ion, the increased medical use of platinum 
compounds has l ed to a growi ng need for the determination of platinum levels in various 
biological samples [ 7 1 ] . 
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Dal ia Hanafi, et a 1 ;  have reported that I -hydroxyethyl-4- [ (3-methyl -6-
methoxybenzothaiazole-2-yl id ine)methane] quino l ium bromide (TOMEHE), a derivati ve 
of thiazole  orange which i capable of  s ign ificant l  greater fluorescence enhancements 
o er the intercalator eth id ium bromide (EtBr), may be useful for quant itat ive 
determ ination of DNA hybrid ization. TOMEHE demonstrated 1 0-fold greater 
fluorescence i ntensity over ethidium bromide (EtBr) when measured at 488 run when 
bow1d to dsD A. The l inear i ty of fluorescence intensity response for TOMEHE when 
bound to dsD A was poor (r
2
=0.566) over the range of studied ( 1  :60 to 1 :  I dye : base 
pair ratios), but improved at dye: base pair ratio  ranges below 1 :  1 2  [72 ] .  
Interact ion between adriamycin  (DXH) which is  an  anthracycl ine ant ibiot ic widely 
used as ant i tumer agent that binds to DNA by intercalation between base pai rs and 
i nhibi ts RNA transcription and DNA was studied using Hg e lectrode. In a weakly acid ic  
media of pH 4 .0-7 .0, the add i ti on of DNA to DXH solut ion results in  the decrease of 
redox peak currents. In the presence of DNA, no new peak appears and the standard rate 
constant ks d id  not significantly change. The bind ing of DXH to DNA by e lectrostatic 
attracti on and i ntercalation forms a k ind of supramolecular complex DXH-DNA, which i s  
electrochemical ly  non-act ive .  The equi l ibrium constant for the complex was calculated. 
The decrease peak current is proporti onal to DNA concentration and can be used to 
determine DNA concentrat ion [ 73 ] .  
Hong Cai , used col lo id Au-enhanced DNA immobi l i zation for the e lectrochemi cal 
detection of sequence spec ific  DNA [ 74 ] .  Self assembly of approximately 1 6-run 
d iameter col lo idal Au onto a cysteamine mod i fied gold electrode resul ted i n  an easier 
attachment of an o l igonucleotide with a mercaptohexyl group at the 5' -phosphate end, 
and therefore an i ncreased capacity for nucle ic acid detect ion. The detect ion l imi t  was 5x 
1 0.
1 0  
mol r l  of complementary ssDNA, which is  much lower than their previous 
electrochemical DNA biosensors [74 ] .  
A single stranded ssDNA-thymidyl ic  acid i cosanucleotides were synthesized o n  the 
surfaces of deri vatized quarts optical fibers to create an optical DNA biosensor. The 
covalently immobi l i zed o l igomers were found to hybrid ize with complementary ssDNA 
(c DNA) or ssRNA (c RNA)  from solution, and the device was regenerable for mult iple 
cyc les of  appl i cat ion.  Hybrid ization on optical fibers was detected by the use of the 
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fluorescent D A stain eth id ium bromide (EtBr). The procedure used hybrid ization assay 
techniques and provided a detect ion l imi t  of 86 ngmL- ' c DNA and a sensit ivity of 200% 
fluorescence i ntensity i ncrease per 1 00 ngmL- ' of c DNA with one cycle of hybrid ization 
analys is  requir ing 45 min .  The extent of hybrid ization between the i mmobi l i zed and 
complementary nuc leic acid strands was determined by U V  absorbance Thermal 
denaturation studies where in  al l 20 bases on each strand of the nucle ic acid were found to 
be i nvolved in  duplex fonnation [ 75 ] .  
A voltmmetric  method for detennin ing guanme and adenine i n  syntheti c  
o l igonucleotides and denatured DNA and RNA in phosphate buffer, pH 4 using a 
Nafionlrutherruum oxide modified electrode was reported . Guanine and adenine were 
adsorbed on to the electrode by applying a potent ial of -0.2  V vs. Ag/AgCI for 30 s. The 
cal ibration graphs were l i near for up to 5 m icro g/ml .  The detection l imits were 1 1 . 5 and 
39 .7  ng/ml ,  respect ively [ 76] . 
Nakahara et a l '  have used HPLC with electrochemical detection for DNA and RNA 
assays through guanine detennination. DNA and RNA extracts of from rat t issues in  
trichloroacetic acid  were hydrolyzed i n  HCl .  L iberated guanine was separated by HPLC 
on a column of E icompak MA-ODS with 0 . 1 M sodium phosphate buffer (PH 4) 
contain ing 1 0  mg mr ' of Na2EDTA and 2% of methanol as mob i le phase ( 1 .0 mI) .  
E lectrochemical detection was done using graphite working electrode. Cal i brat ion graphs 
were rect i l i near for 0 .25 to 4 .0  p/mol .  detect ion of cal f thymus DNA or RNA was 
possible down to 0 .2  ng/ml [77 ] .  
A new symmetric cyanine dye has been synthesized and i ts i nteraction with 
d ifferent DNA has been i nvest igated as a m inor grove binding dye. L inear and c ircular 
d ichori sm studi es indicate that BEBO binds in  the minor groove to ploy [ (  dA-dT)h, but 
that the binding to calf thymus DNA i s  heterogeneous, al though st i l l  with a s ign i ficant 
contribution of m inor groove binding. S im i lar to other DNA binding asymmetric cyani ne 
dyes, BEBO has a l arge i ncrease in  fluorescence i ntensity upon bind ing and a relatively 
large quantum yield when bound . The minor groove binding of BEBO to ploy [ (dA-dT)h 
affords roughl y  a l 80-fold i ncrease i n  intensity, which i s  larger than to that of the 
commonly used other minor groove binding probes such as DAPl and Hoechst 33258 
[ 78 ] .  
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Thulstrup, et al ' studi ed the interact ion between El lagic acid with calf thymus DNA 
to see the underlying mechan i sms of the anti carcinogenic and enzyme i nhib itory effects 
of e l lagic acid .  Based on nonnal absorpt ion ti trat ion and flow l inear d ichorism 
e periment , i t  was confirmed that the neutral form of el lagic acid present at pH 5 . 5  binds 
to ds D A .  I t  was found that the plane of the el lagic acid  chromophore is posit ioned at an 
angle relative to the DNA hel i x  ax is, which i s  in accordance with i ntercalat ion of el lagic 
acid in  DNA.  Results also showed that at h igher values of pH no or a very l imi ted amount 
of e l lagic acid binds to DNA [ 79) .  
A series of new unsymmetrical perylene d i imides have been synthesized to 
i nvestigate their b ind ing select ivi t ies to G-quadrplex DNA structure. The structures of the 
perylene d i im ides ha e been characterized by IR spectrophotometer, H NMR, vis ib le 
absorption and fluorescence emission spectra i n  phosphate buffer solution. Among 
d i fferent l igands, PYPER has been found to be the most se lect ive i nteract ive l igand for 
G-quadruplex DNA as i t  shown a signi ficant selectiv i ty to d(TTAGGG) repeats .  
Fluorescence quenching experiments between PYPER and DNA showed that the binding 
mode of an intercalat ion way [ 80) .  
The interacti on of ct-DNA with some complexes l i ke [pyda]2 [Co(phendc)2] has 
been studied with i sothermal calorimetry ( ITC), U V  -vis spectrophotometry and 
potent iometric t i trat ion.  The results showed that binding of DNA with these complexes 
caused a conformational change in  the structure of the DNA [ 8 1 ] . 
A new spectrophotometry and spectrofluorimetry methods of measunng the 
equi l ibria and k inetics of the interaction of the Zn( I I )  and Cu( I I )  complexes of the 
eotrien with calf thymus DNA have been reported. At low dye/polymer ratios, both 
complexes bind to DNA by in tercalat ion mode. Fluorescence t i trations, where the meta­
eotrien complexes were added to DNA previously saturated with EB, showed that both 
complexes d isplace EtBr from the DNA cavi t ies .  This observat ion suggested that binding 
of Cu-Neotrien induces deep al terati ons in  the DNA structure [ 82 ) .  
New sensit ive, rel iable and reproducible fluorimetric methods for determ i ning 
microgram amounts of nucleic ac ids  based on their reactions with Fe ( I I ), Os ( I I I ) or Sm 
( I l l )  complexes of 4,7-d iphenyl - l , 1 O- phenanthrol ine were proposed . Two 
complementary s ingle stranded syntheti c  DNA sequences based on cal f thymus as wel l as 
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their hybrid ized double stranded were used. Nucleic acids were found to react 
instantaneously at room temperature i n  Tris-CI buffer pH 7, with the investigated 
complexes resu l ting in decreasing their fluorescence emi ssion. L inear ca l ibration graphs 
in the range 1 -6 �g/ml were obtained. Detect ion l imits of 0.3 5-0.98 �g/ml were obtained. 
Using the cal ibrat ion graphs for the synthet ic dsDNA, re lat ive standard deviat ions of 2 .0-
5 .0% were obtained for analyzing DNA in the extraction products from calf thymus and 
human b lood . Corresponding Recovery % of 80- 1 1 4  were obtained .  Student t- values at 
95% confidence level showed insigni ficant d i fference between the real and measured 
values. Resul ts obtained by these methods were compared with the ethid ium bromide 
method using the F-test and sat isfactory results were obtained. 
The association constants and number of binding s i tes of  synthetic ssDNA and 
dsD A with the three complexes were estimated using Rosenthanl graphic method . The 
interaction mechan i sm was d iscussed and an intercalat ion mechani sm was suggested for 
the binding react ion between nucleic acids and the three complexes [ 83 ] .  
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Levofloxacin;  (C l sH20FN304); (9-fluoro-2,3-dihydro-3 -methyl- 1 0-( 4-methyl - l ­
piperazinyl -7 -oxo-7Hpyrido[ 1 ,2 3 -de ] - 1 ,4-benzoxazine-6-carboxylic acid is one of  the 
comm only used fluoroquinolone ant imicrobials that have excel lent activity agai nst 
various bacteria with low frequency adverse effects on oral administrat ion. It exerts 
ant i bacterial activity via antagonism of the interaction between bacterial DNA gyrase and 
cel l DNA.  Levofloxac in is active against several bacterial strains such as gram-posit ive 
aerobic streptococcus pneumonia, staphylococcus aurous, gram-negative escherichia col i ,  
moraxeJ la catharral is  haemophi l us influenza, k lebsie l la pneumonia, pseudomonas 
aeruginosa and intracel lu lar pathogens responsible for atypical pneumonia [84] .  These 
broad range of act ivity against pathogens in vi tro made levofloxacin the drug of choice 
for treating community -acquired pneumonia (CAP), acute max i l l ary sinusit is and acute 
exacerbation of chronic bronchit is .  Because of its h igh t issue di stribution, levofloxacin 
was also used in  bronchoalveolar lavage (BAL) and bone d i seases [ 85 ] .  Approximately 
87% of admin istrated levofloxacin dose is excreted unchanged in urine within 48 hours . .  
Interaction of levofloxacin,  with calf thymus DNA was studied by cyc l ic  
voltarnmetry at  g lassy carbon electrode. A l inear dependence of currents on concentration 
was observed [86] .  
R ifampicin, 3 -((( 4-Methyl - I -piperazinyl) - imino)-methyl) 
ri famycin ;  is  a semi-synthet ic bactericidal antibiotic, act ive in  vi tro against gram-posit ive 
microorganisms and mycobacteria. Ri fampicin i s  used in  combination with i soniazid 
( isonicotinic aci d  hydrazide) and pyrazinamide (pyrazinecarboxamide) for intensive 
treatment of pulmonary tuberculosis [87-88] . Approx imately 30% of the drug is excreted 
unchanged in the urine within 24 hours of admin istrat ion. 1 5% is excreted as active 
metabol ite and about 55% is excreted in stoo l .  The adul t  recommended daily dose of 
r ifampic in i s  600- 1 200 mg. 
Because of  their wide appl ications, sensit ive and selective analytical methods are 
sti l l  requi red to quantify levofloxacin and rifampicin concentrations in d i fferent 
biological matrices. The aim of this work is to develop advantageous and competit ive 
selective NMR methods for determining the two drugs in  pharmaceutical and human's 
urine samples .  
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Fig. l . I 8  Molecular structure of 5- iodo-2 ' -deoxyurid ine 
5- iodo-2 '  -deoxyurid ine;  (C6H ) )N20s); ( l -(2-Deoxy-J3-D-ribofuranosyl)-5- iodourac i l )  i s  
an efficient i nducing agent of oncomaviruses i n  mouse cel l s  [ 89 ]  and potent inhib i tor of  
thymidine k inase and thymidylate synthetase that i ncorporate wi th v iral DNA [89] .  I t  i s  a 
cytotoxic nitric oxide (NO) donor-nucleoside dual action prodrug designed to exploit 
both 0 and an antimetabol i te nucleoside for cancer therapy [90] . I t  was reported that 5-
iodo-2 -deoxyurid ine had ant i  cytopathogenic effect agai nst red neck d isease virus  i n  
room temperature and pH 7 as  i t  i nh ibited soft-shel led turt le ir idovirus (STIV)repl ication 
[9 1 ] . Radiolabel led 5- iodo-2 ' -deoxyrid ine was invest igated as an alternative to [ 1 8F]_2_ 
fluoro-2 -deoxy-glucose as a pharmacodynamic  probe for use with positron emission 
tomography (PET) i n  studies of  early prol i ferative response to ant icancer treatment [92 ] .  
Effects o f  5- iodo-2 ' -deoxyurid ine a s  a n  antiviral drug on human corneal cel l s  i n  vi tro 
was reported . The influence of tox ic i ty of d ifferent experimental parameters was 
evaluated. In condi t ions where corneal epithe l ium is poorly populated and ulcerated, 
wound hea l ing can be delayed by antiv iral medication [93 ] .  It i s  reported that 5 - iodo-2 ' ­
deoxyuridi ne conjugated to  lactosylated poJy-L- Jysine might  consti tute effect ive therapy 
against viral i nfections such as chronic hepat i t is  B, which involve the parenchymal l i ver 
cel l  [94 ] .  
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Fig. l . 1 9 . Molecular structure of A BTS 
ABTS; (C I 8,H24,N6,06,S4); 2 ,2 '  -Azino-bis(3-ethylbenzthiazo l ine-6-sul fonic acid) 
i s  a peroxidase substrate suitable for ELISA procedures [95 ) .  Thi s  substrate produces a 
soluble end product that i s  green in  color and can be read spectrophotometrical ly at 405 
nm [96) .  ABTS is wel l  known substrate for enzymatic peroxidase tests [97),  
percarboxyl ic  acid analysis [98] ,  and selective determ inati on of react ive bromine and 
chlorine species [99] . 
ABTS i s  ox id ized undergoing a one-electron transfer ( 1 00) . The react ion product 
ox idized ABTS is a stable green colored radical . It has a broad absorbance spectrum 
contain ing several max ima with high molar absorpt ivi ties at 4 1 5 , 650, 728,  and 8 1 5  nm 
( 1 0 1 ) . The radi cal can be generated from ABTS in various systems :  enzymatical ly using 
myoglobin ( 1 02 )  or horseradi sh peroxidase [ 1 03 ] ;  chemical ly with Mn02 [ 1 04] ,  
potassium persul fate [ 1  05]or perox ide rad icals [ 1 06] ; or even electrochemical ly [ 1 07 ] .  
Several methods used to  evaluate activ i ty of ABTS. It was reported that 
sequenti al i njection analysis system was appl i ed to evaluate act iv i ty of ABTS ( 1 08 ) .  I t  
was proved that ABTS could be  used with i t s  ant i - inflammatory propert ies for the down 
regulation of free radi cal mediated pathway of inflammation ( 1 09 ) .  A l so A BTS was used 
as adrenergic chatechol derivatives, indicati ng that ant ioxidative activ i ty of thi s  agent are 
evidently due to scavenging free radicals that may not protect from biological damage 
induced by hydroxyl radicals ( 1 1 0) .  New method of photometric determination of 
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reactive bromine and chlorine specles with ABTS was reported .  The bromine and 
chlorine reacts with ABTS to green colored product that is measured at 405 and 728 run .  
Thi s  method i s  suitable for combinations of two dis infectants, provides detection l imi ts of  
bromine and ch lorine species of less than 0. 1 )lM, and the colored reaction product i s  very 
stable and al lows the fixat ion of bromine / chlorine species i n  the field and subsequent 
determination of the absorpt ion in  the laboratory [ 1 1 1 ] . 
A new system for amperometric- biosensor determination of d i ssolved oxygen 
and i ts appl ication for the detection of anionic toxic  substances, which are known as 
enzyme inhib i tors has been studied.  Thi s  biosensor is based on the co- immobi l ization of 
laccase from Trametes versicolor and a redox active layered double hydroxide [Zn-Cr­
ABTS] on a g lassy carbon electrode. The electrochemical transduction step corresponds 
to the electrocata lyt ic  reduction of O2 at 0.2 V by laccase as catalyst and ABTS as 
mediator. This device provided a fast and a sensit ive response for d issolved oxygen 
determ ination between 6 x 1 0-8 and 4 x 1 0-
6 
M [ 1 1 2] .  
A new method for identification and quant ification of phenol ic acids  i n  
concentrated peat extract samples . .  The method was val idated and i t  was suitable for the 
analys i s  of pheno l ic  acids i n  peat extracts. This method a l lowed ident ifying e ight 
phenol ic  acids i n  peat extracts. A l so sl ight variations i n  total phenol ic  content were 
detected. The ant ioxidant act iv i ty of peat extracts was evaluated with spectrophotometric 
ABTS assay. D ifferences in ant ioxidant act ivi ty were observed for two samples of peat 
extract produced from d ifferent peat varieties. These d i fferences probably refl ected 
phenol ic composit ion of peat extracts [ 1 1 3 ] .  
A i m  of the  s tudy 
I .  To study i nteraction modes between DNA and some drug molecules or 
compounds .  
2 .  To develop some spectrophotometric and fluorimetric methods to  determine and 
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Experimental : 
2. 1 .  M a terial  a n d  Reage n ts :  
All  chemicals were of  analytical reagent grade o r  the highest purity avai lable. 
Mi l l ipore deionized water was used throughout. 
20 and 40 bases desalted HPLC or PAGE puri fied o l igonucleotide primers with the 
fol lowing sequences were purchased from Invitrogen L ife Technologies Switzerland. 
I )  (5 ' to 3 ' )  A IT TCC AAG AAA CGC AAG GT designated D J J 
2) (3' to 5 ' )  ACC ITG CGT ITC TTG GAA AT designated D J 2  
3)  ( 5 '  to 3 ' )  TGC CCT CAA ATA CAA CAA AAC AAC A G A  AAC AAA ACA AAA 
A designated Cs 
4) (3 ' to 5 ) TTT TTG TTT TGT TIC TGT TGT TTT GTT GTA TTT GAG GGC A 
designated C6 
The molecular weights of D J J  and D 1 2  are 6 1 3 5 .0 and 6099.0  Daltons, respectively. A lso 
the molecular weights of C5 and C6 are 1 2232 .0 and 1 2354 .0  Daltons, respectively. 
Calf thymus DNA from male and female calf thymus ti ssue with molecul ar weight 
of 1 0- 1 5  m i l l ion Daltons containing 4 1 .9 mole% G-C and 58 . 1 mole% A-T l inkages was 
purchased form Sigma-Al drich.  
Human DNA was extracted from blood sample using QIAGEN Mini Kit  and QIA 
Blood Mini  Kit  (B lood Spin Protocol) .  
5- iodo-2 -deoxyurid ine, Ri fampicin, levofloxacin  and 2 ,2 '-Azido-bis(3-
ethylbenzothi azol ine-6-sulfonic acid) d iam monium salt (ABTS) were purchased from 
igma and used without any further puri fi cat ion. 
HgCI2, MgS04, ZnCb, D L-Val ine, CoCI2, PbN03, CaCb, CUS04, G lycerin, CdCh, 
FeS04,  and A lan ine purchased from Sigma Aldrich were used for interference. 
2.2. Apparatus 
Fl uorescence measurements were made using Cary Ecl ipse model-3 fluoremeter 
(Varian, Austria) equipped with a h igh intensity Xenon flash lamp. 
pH metric measurements were carried out using Orion research 40 I -plus pH meter 
supported with Orion g lass e lectrode. 
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UV - I spectrophotometer measurements carried by (Cary 50) matched with 1 em 
quartz or s i l i ca cel l s  used for absorpt ion measurements. 
F ig .  2 . 1 .  Cary Ecl ipse-3 fluoremeter. 
Fig. 2 . 2 .  Cary-50  UV-Vis  spectrophotometer. 
2.3  Sta n d a rd solutions 
0. 1 M phosphate buffer with pH 4, 5, 6, and 7 were prepared by the standard 
procedure. The pH was adjusted using glass electrode. 
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Purchased nucle ic acids were reconst i tuted by centri fugat ion for 2 minutes at 7000 
rpm to col lect the ON at the bottom of the tube .  A 2 ml of deionized water was added 
and left 2 minutes for rehydration then vortexed for 1 5  seconds. Reconsti tuted primers 
were kept in freezer t i l l  use . Stabi l i ty of reconst ituted primers was more than 6 months. 
Calf thymus dsDNA 1 000 Ilglml was prepared by d issolving 1 0 .0 mg of DNA into 
1 0  ml of deionized water with/without add ition of 2-3 crystal s  of EDT A without 
sonicat ion or st irring. To prevent shearing of the large genomic DNA, the solution was 
gently inverted overnight at 0-4°C to completely solubl ize the DNA .  Solutions of DNA 
are stable for several months at 4°C in  phosphate buffer pH 7.0 A 1 0 .0  ppm Calf thymus 
D A was prepared by accurate d i lut ing of o. I ml DNA solution into 9.9 ml phosphate 
buffer pH 7.0. 
A 200 Ilg/ml stock standard of 5 -iodo-2 ' -doxyurid ine, Levofloxacin,  R ifampicin 
and AzBTS were prepared by d issolving 0.0 1 g of each drug into 50.0 ml  deionized 
water. Lower concentrations were prepared by accurate d i lution. 
H uman dsDNA was extracted from blood samples col lected in  heparenized tube 
using Q IAGEN B lood and Body Fluid Spin Protocol . H uman DNA was reconst ituted by 
centrifugation for 1 m inute at 7000 rpm to col l ect the DNA in  the bottom of the tube .  A 
1 .0 ml of deionized water was added and left overnight at 0-4 °C,  then vortexed for 30 
seconds. Reconsti tuted DNA was kept in  freezer t i l l  use. 
2.4 Proced u res 
2 .4. 1 .  Spectrophotom etric q u a n titat ion of prepa red ol igonu cleot i d es 
A 1 0  or 20 III of resuspended synthetic  CD " ,  D 1 2 ,  C5 or C6) cal f thymus or natural 
human DNA was d i l uted to a final volume of 1 000 III using Mi l l ipore deionized water. 
The sol ution was vortexed for 1 5  seconds and its absorbance was measured at 260 nm .  
The concentration was calculated using the fol lowing formula :  
Concentrat ion in  fig/m l = A 260 X Weight per O D  x d i l u tion factor 
OD is the opt ical density at 260 nm .  The puri ty of the o l igonucleotide was tasted by 
calculat ing the rat io  A260/ A28o. Factor of 2: 1 . 8 were obtained for synthetic and natural calf 
thymus and indicated h igh purity. A factor of 1 . 8 was obtained for human DNA 
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ind icating high pure D A extract. The reason is attributed to the high quality of the 
extraction kit  used. 
The fol lowing concentrat ions were obtained for synthetic DNAs D ] ]=538 .7  ppm, 
D ] 2= 69 1 .67 ppm, Cs= 278,4 ppm, C6= 327 ppm. Solutions having concentrat ions of 
5 . 38, 6.9 1 ,  2 . 78  3 .27 ppm were respectively, prepared by accurate d i lution into 
phosphate buffer pH 7 and were used throughout in al l  experiments according to the 
equivalent concentrations. 
2 04.2 Hyperd iza t ion of sy n thetic ol igonu cleotides 
Double stranded DNA was prepared by mixing equimolar amounts of the 
complementary synthet ic primers CD ] ] and D l 2  or Cs and C6) in appropriate amount of 
phosphate buffer pH 7 .  The solution was vortexed for 1 5  seconds, incubated at 50 °c for 
30 minutes and then left to cool to room temperature. Hybridized dsDNA was kept in  
refrigerator t i l l  use. 
2 .4.3. Extract ion of H u m a n  DNA 
The fol lowing protocol was used for extracting human DNA from blood sample 
1 - A 20 III QIAGEN Protease (or Proteinase K) were put into the bottom of a 1 . 5 ml 
microcentri fuge tube. Fol lowed by adding 200 III blood to the tube. 
2- 200 III Buffer AL were added to the sample and mixed by pulse-vortex for 1 5  s. 
o 
Resultant solution was incubated at 56 C for 1 0  min then, the 1 . 5 ml  tube was 
centrifuged to remove drops from the inside of the l i d .  
3 - A 200 II I  absolute ethanol was added to  the sample, m ixed again by  pulse-vortexing 
for 1 5  s and briefly centrifuged to remove drops from the inside of the l id .  
4- The mixture from step 3 was carefully appl ied to  the QIAamp Sp in  Column ( in a 2 ml  
col l ection tube) without wett ing the r im and centri fuged at  8000 rpm for I min .  Then, the 
QIAamp Spin Column was placed in a c lean 2 ml col lection tube and the tube containing 
the fi ltrate was discarded . 
5 - Carefully the QIAamp spin Column was open and 500 III Buffer AW l were added 
without wett ing the rim then centrifuged at 8000 rpm for I min.  The QIAamp Spin 
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Column was placed in a c lean 2 ml col lection tube and the col lection tube containing the 
fi ltrate was d iscarded . 
6- Again. the QIAamp pm olumn was carefu l ly  open and 500 �I Buffer A W2 were 
added without wetting the rim .  The column was then centrifuged at 1 4 ,000 rpm for 3 min .  
7- The QIAamp pin o lumn was then placed in a clean 1 . 5 ml microcentrifuge tube and 
the col lection tube containing the fi ltrate was discarded. Careful ly the QIAamp Spin 
Column was open and 200 � l Buffer AE or dist i l led water was added . Resultant solution 
o 
was incubated at room temperature ( 1 5-25 C) for 1 min,  and then centri fuged at 8000 
rpm for 1 min .  
A 200 )ll of whole b lood is expected to y ie ld  3 - 1 2  )lg of DNA .  
2.4.4.  I n terfe re n ce 
1 .0 ml of 20.0 ppm natural calf thymus DNA was mixed with 1 . 0 ml of 20.0 ppm 
ABTS and 200 )ll of 1 0-7 M i nterfering solution. The mixture was made up to 3ml  using 
phosphate buffer, pH 7 and its Absorbance and florescence intensi ty were measured at 
230, 340, and 3 90 nm .  HgCh, MgS04, ZnCI2, DL-Val ine, CoCh, PbN03, CaCh, CUS04 
Glycene, CdCh FeS04, and A lanine were used as interfering substances. 
2 .4.5. Determ i n a t i o n  of b i n d i n g  s i tes a n d  associat ion consta n ts 
The number of binding sites of a nuc leotide residue (n) and the association constant 
(K) of nucleic acids to the investigated complexes were est imated based on the mod ified 
Rosenthal's graphical method using the fol l owing equation [40-4 ] ) . 
So l S 
J 
- = - 1 - - C d X K + nCK + 1 S S rug o 
(2) 
Where S i s  the absorbance or fluorescence intensity measured at the Amax of absorption 
or emission after each addit ion. So is the absorbance or fluorescence intensity of the 
blank sample (at zero �l added) respectively. C is the nucleic acid concentrat ion and 
Cdrug is total concentrat ion of 5 - iodo-2'  -doxyurid ine, Levofloxacin, Rifampicin or ABTS 
within the dynamic range of the cal ibrat ion graph. By vary ing DNA concentration and 
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keeping Cdrug constant, the p lot of SOl as a function of ( I -Sol ) Cdrug gives a straight 
l i ne whose slope is equal K and from the intercept we can find the number of n .  
2.4.6 Spectroph otometric Determ ina tion : 
A 1 .0 m l  of 1 0.0 Ilglml standard solutions of 5- iodo-2 ' -deoxyurid ine, levofloxacin,  
Ri fampicin, and AzBTS were prepared by accurate d i lutions of the stock solution with 
phosphate buffer pH 7 .  The solution was then transferred into 4 ml measuring cel l  and 
1 00 III successive portions of 5 .38 ,  6.9 1 , 1 0  or 20 Ilglml of D ] ] ,  D 1 2, dsDNA or ct-DNA 
respect ively were added.  Absorbance spectra were recorded. Absorbance at 285  nm for 5 -
iodo-2' -deoxyuridine, 255 ,  290 and 3 30nm for levofloxacin, 330, and 470 for r ifampicin, 
260, and 340 nm for A BTS, as Amax of absorpt ion were recorded . Changes in  
Absorbances A were plotted versus nucleic acid concentrat ions in  Ilg/ml after correction 
for d i lution. 
A s imi lar set of measurements were recorded using 2 .78,  3 .27 or 20 20, 20 Ilglml 
of Cs ,  C6, ds(Cs-C6), ct-D A,  and human DNA to 1 .0 ml  of 20 ).l.glml ABTS. 
2.4 .7 .  Flu o remetric determ i n at ions :  
2 .4 .7 . 1 .  R ifampic in :  1 ml ri fampicin with d i fferent concentrations ( 5 , 1 0, 1 5 ,20,30, and 50 
ppm )  were prepared and mixed with equivalent concentrat ions wi th ct-DNA (CT-DNA 
were added in 0 .2 ,  0 .6, 1 ml successive amounts of nuc leic acid) ,  in d i fferent pHs (4, 5, 6, 
7) and measured as Amax of excitation at 335  and 475 nm . I ntense fluorescence bands 
around 470 and 670 nm were observed . 
2 .4 .7 . 1 .  ABTS : a 1 ml of 20 Ilg/ml standard solut ion of ABTS was prepared by accurate 
d i l utions of the stock solut ion with phosphate buffer pH 7. Then it was transferred into 
quartz cel J and ] 0 III successive portions of ct-DNA were added. Fluorescence spectra at 
The fluorescence emission spectra of ABTS measured at 230, 340, 390 nm as Anlax of 
excitation.  Intense fl uorescence bands around 465, 680, and 780 nm were observed . 
Changes i n  fluorescence intensity F were plotted versus nucleic acid concentrat ions 
Ilglml after correct ion of d i lut ion. 
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Chapter 3 
3. 1 .  Characteristic of UV s pectra 
Result and Discussion/Spectrophotometry 
3. 1 . 1 .  Absorption Spectra of 5-iodo-2 '-deoxyuridine 
5- iodo-2 ' -deo ur id ine ( Idoxur id ine) i s  an antiv ira l  drug that is used for treat ing v i rus 
infect ions of the e e by act ing as nucleic acid synthesis inh ibitor [89 90, 92, 93] 
UV absorpt ion spectra of 5- iodo-2 ' -deoxyuridine i s  shown in F igs. 3 . 1 . 1  a-d Two 
absorption peaks at 220 and 285 nm are observed . The band at 220 can be attri buted to n-n * 
transit ion whereas the band at 285  nm can be attri buted to the n-n* transit ion . Addi t ion of 
nucle ic ac ids increments decreased the intensity of the two absorpt ion bands at 220 and 280 
nm.  In  add it ion the absorpt ion band at  260 nm spec ific  for nucle ic ac ids absorpt ion was 
reached max imum at saturat ion.  Two i sosbest ic  points appeared at 240 and 270 nm ind icat ing 
that the react ion i s  dependent on both the drug and nucle ic ac ids .  Th i s  may ind icate that 5-
iodo-2 ' -deoxyurid ine in tercalate with nucle ic acids form ing b inary or tert iary adducts. F igs. 
3 . 1 . 1  a-d show the UV spectra obta ined by adding 1 00 �I successive increments of I 0 �g/m l 
D] ] ,  D ] 2, dsD A or ct-DNA respectively to 1 .0 m l  port ions of the 1 0  �g/m l 5 - iodo-2 ' ­
deoxyuridine i n  phosphate bu ffer a t  pH 7 .  
I ntercalat ing drugs s l ip  between the  l ayers of DNA base pairs and d i srupt ing the  shape 
of the double he l i x  prevent ing DNA rep l icat ion and transcr ipt ion .  Drugs act ing in  th i s  way 
shou ld be flat to fi t between the base pairs and m ust be aromatic or heteroaromatic in nature .  
ome drugs prefer to approach the hel i x  via the major groove, whereas others prefer access 
via the m inor groove [47) .  
I t  seems  that 5- iodo-2 ' -deoxyurid ine approaches DNA v ia  the major grooves of the 
double he l ix and fi t the p lanar heteroaromat ic ring (ur id ine) into the double  he l ix .  The 
chemical structure of i doxurid ine approx imates the configurat ion of thymid ine as one of the 
four DNA bu i ld ing b locks. As  a resu l t, idoxurid ine is able to rep lace/i nterca late thym id ine in 
the enzymat ic step of v i ra l  rep l icat ion or "growth" .  The consequent production of fau l ty DNA 
resu l ts in  a pseudostructure which cannot i nfect or destroy t i ssue. In short, by pre-empting a 
vi ta l  bu i l d ing block i n  the genet ic material of the Herpes s im plex v i rus, Herp lex-D topica l  
so lut ion destroys the infect i ve and destruct ive capac i ty of the v ira l  materi a l .  The v i rus 
i nfected cel l  may on ly  be attacked during the period of act i ve synthesis of DNA .  This  occurs 
early i n  the development of the Herpes s implex lesion, but at d i fferent t imes i n  d i fferent ce l ls .  
Therefore ideal ly, the affected area shou ld remain saturated with the ant iv i ra l  agent .  Thus, 
idoxurid ine acts as an ant iv i ra l  agent aga inst DNA viruses by inh ib i t ing thym id i late 
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phosphorylase and v i ra l  D polymerases [89, 90] . It seems that 5 - iodo-2'-deoxyurid ine 
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Fig .  3 . 1 . 1 a .  UV spectra obta i ned by successi ve add i t ions of 1 00 III port ions of 1 0  )..lg/m l Dl l  
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Fig .  3 . ] . 1  b. UV spectra obta i ned by successive add i t ions of 1 00 III port ions of 1 0  Ilg/m l D1 2  
to 1 .0 m l  of J 0 Ilg/m ! S - iodo-2 ' -deoxyurid i ne in phosphate bu ffer p H  7 .  
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Fig .  3 . 1 . 1  c .  U V  spectra obta i ned by success ive add i t ions of I 00 �1 port ions of 1 0 �g/m l 
dsD A (DWDI2) to 1 . 0 m l  of 1 0  �glm I 5- iodo-2 ' -deoxyur id ine in  phosphate buffer pH 7 .  
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Fig .  3 . 1 . 1  d .  U V  spectra obta ined by success ive add i t ions of I 00 �I port ions of I 0 �glm l 5-
iodo-2 ' -deoxyurid i ne to 1 .0 m i l O  �glm l of ct-DNA i n  phosphate buffer pH7.  
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3. 1 . 2 .  Ab o rpt ion Spectra o f  Levofloxa c i n  
levofloxaci n is  an  anti -ba teria l ,  ant i - infective and qu ino lone agent used for the 
treatment of bacteria l  conj unct iv i t i s  cau ed by suscept ib le  stra ins of the fol low ing organ isms:  
orynebacter ium spec ies, Staphy lococus aureus Staphylococcus epiderm id is, Streptococcus 
pneumon iae, Streptococcus (Groups c/F/G), V i ridans group streptococc i ,  Ac inetobacter 
Iwo ffi i, Haemoph i lus influenzae Serratia marcescens [ 84 ] .  
Levofloxac i n, a fl uoroqu inolone ant i  infect ive, is the opt ica l l y  act ive L- isomer of 
ofloxac in .  Levofloxacin  is used to treat bacteria l  conjunct iv i t is, s inus i t is ,  chronic bronchi t is, 
comm unity-acquired pneumon ia  and pneumon ia caused by pen ic i l l in-res istant stra i ns of 
Streptococcus pneumon iae, sk i n  and sk in  structure i nfections, comp l i cated urinary tract 
i nfect ions and acute pyelonephri t is  [ 85 J .  
Le  oflo ac in  inh ib i ts bacteria l  type I J  topoisomerases, topoisomerase IV  and DNA 
gyrase. Levofloxac in ,  l ike other fluoroqu inolones, i nh ibits the A subun its of DNA gyrase, 
two subun i ts encoded by the gyrA gene. Th is resu lts in strand breakage on a bacteri a l  
chromosome, superco i l ing and resea l i ng; DNA rep l ication and transcript ion are i nh ibited 
[ 84 ] .  
F ig. 3 . 1 .2a shows t he  UV absorpt ion spectra of  levofloxac i n .  Three absorpt ion bands at 
255 ,  290, and 330  nm are observed . These bands can be attr ibuted to n-CJ*, 11:-11:* and n-11:* 
transit ions, respect ive ly .  Successive add it ion of levofloxac in to s ingle and double stranded 
D A (0 , , ,  0 , 2, dsDNA, and ct-DNA), sh ifted the 260 and 280 nm bands spec ific for DNA 
and increased in the in tensi ty of the 330  nm band correspond ing for the levofloxac in (F igs 
3 . 1 .2a-d). The reason i s  attri buted due to the interca lation of nuc le ic  ac ids with the 
levofloxacin .  F igs. 3 . 1 . 2a-d show the UV spectra obta ined by success ive add i t ions of 1 00 fll 
port ions of 1 0  flglm l levofloxac in  to 1 . 0 m I l O  J..lglm l of 01 1 ,  0 1 2, dsDNA or ct-DNA in 
phosphate buffer pH 7. 
I t  seems that levofloxacin  approaches DNA v ia  the major grooves of the double he l i x  
and fit i ts d i azine heteroaromatic r ing into t he  double he l ix .  I t  i s  bel ieved that the b ind ing 
model of levofloxacin  to DNA is based on e lectrostat ic  b ind ing and i ntercalat ion. Further 
investigat ions using c i rcu lar d ichroism w i l l  be carried out to con fi rm intercalat ion 
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Fig.  3 . 1 .2a .  U V  spectra obta ined by success ive add it ions of 1 00 III port ions of 1 0  Ilg/m l 
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Fig. 3 . 1 .2b .  U V  spectra obta i ned by successive add i t ions of 1 00 III port ions of 1 0  Ilglm I 
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Fig.  3 .  J .2c.  U V  spectra obta i ned by success ive add i t ions of I 00 �I portions of I 0 �g/m l 





.0 0.3 <:t: 
0.2 




250 300 350 400 
Wavelength (nm) 
Fig.  3 . 1 .2d .  UV spectra obta i ned by success ive add i tions of 1 00 �I  port ions of 1 0  )lg/m l 
levofloxac in to 1 . 0 m l  I 0 �g/m l of ct-ONA in phosphate buffer pH 7. 
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3. 1 .3.  A bsorpt i o n  Spec t ra o f  A BTS 
ABT , 2 2-az ino-bis(3-ethyl - benzoth iazo l i ne)-6-su l fonic acid-d i ammon ium sa lt ,  a 
color reagent.  \i e l l -known substrate for enzymat ic perox ide tests and percarboxyl i c  ac id 
analysis [97] . The reduced form of ABT is colorless and can be ox id ized by one-e lectron 
tran fer producing A BTS+ as a stable green colored radical  [ 1 00) .  The reduced and oxidized 
forms have broad UV- V 1 S  absorpt ion spectra contai n i ng severa l bands  with h igh molar 
absorpt iv i t ies at 220 340 and at 4 1 5  650, 728, and 8 1 5  nm, respect ive ly [ 1 0 1 ] . S ince the 
reaction with A BTS is fast and has a known stoichiometry, a d i rect ca lcu lat ion of the analyte 
using the molar absorpt iv i ty of the colored oxidat ion product is poss ib le .  
F ig .  3 . 1 . 3a  show the  UV spectra of the  reduced form of ABTS. Two absorption bands 
at 220 and 340 nm are observed . These bands can be attr ibuted to n-n* and n-n* trans i t ions, 
respect ive l . Successive add i t ion of single or double stranded DNA (D ] ] ,  D ] 2, dsDNA, ct­
D A, or human DNA) have shown to decrease or d im in ish the intens i ty of the absorpt ion 
band at 220 and 340 nm speci fi c  for A BTS. Meanwh i l e  the i ntens ity of the bands at 260 nm 
specific for DNA is i ncreased . Two isosbest ic points appeared around 240 and 290 nm 
ind icat ing that the react ion i s  dependent on both the A BTS and nuc le ic acids molecules. F igs. 
3 . 1 .3a-e shows the UV spectra obtai ned by successi ve add i t ions of the Cs, C6, dsDNA, ct­
D A, and human DNA at concentrat ion of 20 flglm l to 1 m l  A BTS ( l O-20 flglm l )  In 
phosphate buffer pH 7. 
1 t  seems that A BTS approaches DNA via the major grooves of the double he l ix  and fit 
into the double he l i x .  Th is  may ind icate that A BTS intercalate with nuc le ic  acids form ing 
adduct by interca lat ion mechan ism. 
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F ig. 3 . 1 . 3a. UV spectra obta i ned by success ive add i t ions of 1 00 �I port ions of 20 �g/m l Cs to 
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Fig.  3 . 1 . 3b .  UV spectra obta i ned by success ive add i t ions of 1 00 �l port ions of 20  �g1m l C6 to 
1 . 0 ml of 20 �g1m l A BTS in phosphate buffer pH 7 .  
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Fig. 3 . 1 .3c .  U V  spectra obta i ned by successive add i t ions of I 00 �I port ions of 20 �g/m I 












Fig. 3 . 1 . 3d .  UV spectra obta ined by successive add i t ions of I 00 �I port ions of 20 �g/m l ct­
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Fig .  3 .  J . 3e .  U V  spectra obta ined by success ive add i t ions of J 00 ).11 port ions of 20 ).1g/m l 
H uman D A to 1 .0 m l  o f 20 ).1g/m l A BTS in  phosphate buffer pH 7 .  
3. 1 .4.  Absorption Spectra of R ifampicin 
R i fampic in, (C43HssN40d; 3 -« (4-Methy l - I -p i peraz iny l )  - i m ino)-methy l )  r i famyci n ;  i s  
a sem i -synthet ic bacteric ida l  ant ib iot ic, act ive in v itro aga inst gram-pos it ive m icroorgan isms 
and mycobacter ia .  R i fampic in  is  used in  com binat ion with i soniazid ( i son icot i n ic ac id 
hydrazide) and pyraz inam ide (pyrazinecarboxam ide) for intens ive treatment of pu lmonary 
tubercu los is  [ 8 7-88] .  
F igs .  3 . 1 .4a show the U V  absorpt ion spectra of ri fampic i n .  Three absorption bands 
around 230, 340, and 480 nm are observed. These bands can be attr i buted to n-cr*, 1t-n* and 
n-n* transi t ions.  respect ive ly .  Successive add i t ion of s ing le and double stranded DNA (Cs, 
C6, and ct-DNA)  to r ifampic in  have shown to decreases the intens i t ies of the three bands 
correspond ing to r ifamp ic in  (F igs 3 . I .4a-c). The band at 260 nm spec i fic for DNA is shown 
to i ncrease by add i t ion of DNA .  The reason is attr ibuted due to the i n terca l at ion of nucle ic 
ac ids w ith the r i famp ic i n .  F igs. 3 . I .4a-c show the U V  spectra obta ined by successive 
add i tions of 1 00 ).11 port ions of 1 0  ).1g/m l Cs, C6 or ct-DNA to 1 .0 ml 1 0  ).1g/m l of r ifampic in in 
phosphate buffer pH 7 .  
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It eems that ri fampic in approaches DNA via the major grooves of the double he l ix and 
fit i n to the doub le  he l ix .  I t  i s  be l ieved that the b inding mode l of r ifampic in DNA i s  based on 
intercalat ion mechan ism.  
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Fig.  3 . 1 .4a .  UV spectra obta i ned by success ive add i t ions of 1 00 J..l 1 port ions of 1 0  /J.g/m l Cs to 
1 .0 ml of 1 0  J..lg/m l  R i fampic in in phosphate buffer pH 7.  
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Fig. 3 . 1 .4 .b .  UV spectra obta i ned by success ive add i t ions of 1 00 J..l1 port ions of 1 0  J..lg/m l C6 to 
1 .0 ml of 1 0  J..lg/m i R i fampic in i n  phosphate buffer pH 7.  
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Fig. 3 . 1 .4c .  UV spectra obta i ned by successive add it ions of 1 00 )11 port ions of J 0 )1g/m l 
R ifampic in  to 1 .0 m l  of 1 0  )1g/m l ct-DNA in phosphate buffer pH 7.  
3.2.  Optimizat ion of Reaction Conditions 
3. 2. 1. Reaction Time 
The binding react ions of nucle ic ac ids wi th  the 5- iodo-2 ' -deoxyurid i ne,  levofloxac in, 
ABTS, and r ifampic in  were found to be complete in  less t han I m i n  at room temperature. 
Decreases in absorbance i ntensit ies and/or sh i fts of Amax of absorpt ion caused by the 
addi t ion of nuc le ic  ac ids  were shown to remain constant for 2: 30 m inutes after addi t ion. This 
g ives an ind ication about the rate of the interaction of these drugs wi th  DNA.  However, 
reaction t imes � 5 .0  m inutes were previously reported [ 52 ] .  
3. 2. 2. A ddition Order of Reagents 
The add i t ion order of reagents was found to hard ly have an i nfluence on the change of 
absorbance i ntens i ty of i nvestigated nucle ic acids intercalates with 5 - iodo-2 '-deoxyurid i ne, 
levofloxacin, ABTS, and ri fampic in .  Addi t ions orders was inverted to see the effect of add ing 
e i ther DNA to drug or Drug to DNA as shown in Figs 3 . 1 . 1  d .  and 3 . 1 .4c .  No sign ificant 
changes were observed. 
56 
Chapfer Results and Di cussioniSpecfrophotometry 
3. 2.3. Effect 0/ Incubation Time 
The e ffect of temperature and i ncubation t ime on 5- iodo-2 ' -deoxyuridi ne, 
levofloxacin ,  A BT , and r ifampic in i ntercalates with s ingle and double stranded nuc le ic 
ac id were i n  e t igated . The intens ity of absorpt ion at Ama of respect ive compounds was 
found stable with no s ign i ficant change for up to 48 hours at room temperature .  During th is  
period invest igated ssDNA and dsDNA complexes i nterca late were shown to be stable.  
3. 2. 4. Molar Ratio, Dy n a m ic Ra n ge and Sensi t iv i ty 
The molar rat ios of  nuc le ic  acids-drugs intercalates were determ ined using the molar 
rat io method . Successive amounts ( 1 00 ).11 port ions) of nuc le ic  ac ids ( 1 0-20 ).1g/m l )  were 
added to I ml ( 1 0-20 �g/m l )  of 5- iodo-2' -deoxyurid ine levofloxacin ,  A BTS or r ifampic i n  i n  
phosphate buffer pH 7 .  P lots of absorbance versus concentration in �g/m l were plotted a t  the 
Amax of absorbance for either the 0 A (260 nm) or the i nvest igated compound (285 nm in 
case of 5 - iodo-2 ' -deoxyurid i ne,  290 in case of levofloxac in ,  340 nm in  case of A BTS and 
475 nm in case of r ifampc in ) .  The Plots of absorbance versus concentration confirmed ] :  1 
mass rat io  of DNA :  drug/com pound intercalates ( F igs . 3 . 2 .4a-h) .  
L inear ranges, regression equat ions, ca l i brat ion sens i t i v i t ies, and corre lat ion 
coefficien ts performance c haracterist ics of the regression I ines for the interact ion of DNA 
with investigated compounds are g iven in Table 3 . 2 . 1 .  Th is  va lues are good enough for us ing 
i nvestigated compounds as probes for nucle ic acids determ inations. 
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Ie .  3 . 1 .  Li near ranges regression equations, and corre lation coeffic ients performance characterist ics of the 
e loped methods for determ in ing d i fferent nuc le ic  acids spec ies. 
uc l ic acid 
Linear ranges 
()..lg/m l)  
Li near regression 
equat ions 
a) Using 5 - iodo-2 -deoxyurid ine as probing species (260 nm) 
0 1 1  (ssD A) 0 .9-6.4 Y=O.O I X+0. 1 302 
dsDNA 0.9-5 . 8  Y=O.O I X+O. J 283 
ct-O A 1 .6-7.3 Y=0.0 ] X+0.2082 
b) Using 5 - iodo-2 ' -deoxyurid ine as probi ng spec ies (285 nm) 
D I I  (ssDN A) 0.9-6.6 Y=-O.O ] X+0.2 1 48 
dsD A 0.9-6.8 Y=-0.0 I X+0.2332 
ct-O A 0.9-7 .5 Y=0.02X+0 .0889 
c) Using l evofloxac in as probing species (260 nm) 
0 ] 1 (ssDN A) 0.9-6.6 Y=0.02X+0. 1 945  
D I 2 (ssDNA)  0 .9-6.6 Y=0.02X+0.2403 
dsDNA 0.9-6.6 Y=0.05X+0. 1 697 
ct-ONA 0 .95 -5 . 7  Y=0.02X+0.2032 
d) Using levofloxac in  as probing spec ies (290 nm) 
0 ] ]  ( ssDN A)  0 .9-6.6 Y=0. I X+0 .0375 
D ] 2 (ssDNA) 0.9-6.6 Y=0. I X+0.0549 
dsDN A  0.9-6.4 Y=0. l X+0 .0 1 68 
ct-DNA 0 .9-6.6 Y=0. I X+0.0522 
e) Using , A BTS as probing spec ies ( 260 nm) 
C5 (ssDNA )  0 .9-6.6 Y=0.0 1 X+0. 1 229 
C6 (ssDNA )  0 .9-6.6 Y=0.0 1 X+0. 1 5 5 8  
dsDNA 0.9-6.6 Y=O.O IX+0. 1 5 3  
ct-DNA 1 .6-6.6 Y=0.0 I X+0. I O I 7  
f) Using , ABTS as probing spec ies (340 nm) 
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slope 
0.0 1 0 .98 
0.0 ] 0 .96 
0.0 ] 0 .99 
0.0 1 0 .99 
0 . 0 1  0 .99 
0 .02 0 .99 
0.02 0.99 
0 .02 0.98 
0.05 0.97 
0 .02 0.99 
0 . 1 0 .99 
0 . 1 0 .99 
0 . 1 0 .99 
0 . 1 0 .99 
0 .0 ] 0 .97 
0 .0 1 0 .99 
0 .0 1 0.99 
0 .0 ] 0.99 
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C5 (ssD A) 0 .9-6.6 Y=-0.03X+0.3477 0.03 0.98 
C6 (ssD ) 0 .9-6.6 Y=-0.04X+0.4565 0.04 0.99 
d D A 0 .9-6.6 Y=-0.04X+0 .4506 0 .04 0 .99 
ct-DNA 0.9-6.4 Y=0.03X+0.3 1 6  0.03 0 .98 
g) Using ri fampic in  as probing spec ies (260 nm) 
C5 (ssDNA) 0 .9-5 Y=-0 .002X+0. 1 269 0 .002 0 .98 
C6 (ssDNA) 0 .9-5  Y=-0.00 I X+0. 1 3 78 0.00 1 0 .29 
dsD A 0.9-5 Y=-O.O l X+0.33 8 1  0.0 1 0 .95 
ct-DNA 0.9-5 Y=0 .0 I X+0.2028 0.0 1 0 .99 
h) Using r i fampic in  as probing spec ies (475 nm) 
C5 (ssDNA) 0.9-5 Y=-0.0 I X+0.0625 -0.0 1 0 .97 
C6 (ssD A) 0.9-5 Y=-O.O I X+0.9485 -0 .0 1 0 .94 
dsD A 0.9-5 Y=-0.0 I X+0. 1 73 1  -0.0 1 0 .93 
ct-DNA 0.9-5 Y=0.0 ] X+0.004 0.0 1 0 .99 
eported values for ca l i brat ion graphs at 260 nm and 285 ,  290 nm,  and 475nm . 
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Fig.  3 .2 .4a.  Ca l i brat ion curves for ct-DNA, 0 1 1 and ds(OwDd using 5 - iodo-2 ' -deoxyurid i ne 
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Fig.  3 .2A .b. Ca l i bration curves for ct-ONA, DI I and ds( DwOJ 2) using 5- iodo-2 ' ­
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Fig .  3 .2 .4c .  Ca l ibrat ion curves for ct-ONA, 0 1  I and 0 1 2, ds(OwOI2 )  us ing Levofloxac in  at 
260 n m . 
0 1 1 , 0 1 2 ,  ds(D 1 1 ,D 1 2), ct-D N A  + levofloxacin (1 Oppm, p H 7 ,  at 290 nm) 
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-- 0 1 2  + 0 6  levofloxacin 
---+- ds(D1 1 ,0 1 2) 
+ levofloxacin 
0 5  
E ______ cl-ONA + c levofloxacin I 0 '" roo 
� 0 4  
en D 
4: 0 3  
0 2  
0 1  
a 2 3 4 5 6 7 
DNA Cone.  in u glml 
Fig .  3 . 2 .4d .  Ca l i brat ion curves for ct-DNA, 0 1 1 ,  0 1 2  and ds( OwOn) us ing Levofloxacin at 
290 nm . 
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C S,C6, ds(CS,C6), CT-ONA + Az B T S  (1 0ppm, p H 7 ,  at 260 nm) 
2 3 4 5 6 
DNA Cone. ug/ m l  
-+- C5 + I AzBTS -- C6 + I AzBTS I 
-- ds(C 5,C6) I I + AzBTS j __ Ct-ONA + 
AzBTS 
Fig .  3 .2 .4e .  Ca l i brat ion curves for Cs, C6, ds(Cs-C6) and ct-DNA us ing AzBTS at 260 nm .  
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C5, C6, ds(C 5,C 6 ), and ct- D N A  + R ifampicin ( 1 0ppm, p H 7 )  (260nm) 
1-- C 5  + Rlfa 
--- C6 + Rlfa 
I I II  -- ds(C 5 ,C6) + 
Rifa I 
___ Rifa + ct-DNA 
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C 5 ,  C 6 ,  ds(C5,C6), ct-DN A  + R ifam picin (1 0ppm, pH7,  at 4 7 5  n m )  
6 
DNA Conc. In ug/ml 
- C5 +  Rifa I 
- - C6 + Rifa 
-- ds(C5,C6) + 
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Fig. 3 , 2 . 4h .  Ca l ibrat ion curves for C5, C6, ds(Cs-C6) and ct-DNA using R i fampic in  at 475nm.  
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3. 2. 5. Selectivity 
I nterference of twe l e metal ions and amino acids on the ct-DNA-A BTS interca late's 
complex was invest igated under condi t ions descr ibed in the experimental part .  A 1 .0 ml of 20 
)lgl/m l ct-DNA was added to 1 .0 m l  of 20 j.lg/m l A BTS. A 200 j.ll of 1 0-7 M of e i ther 
interfering substance was added to the m ixture. The vol ume  was adjusted to 3.0 ml us ing 
phosphate bu ffer pH 7 and i ts spectra was measured (F ig. 3 . 2 .6). Values of absorbance at 
220, 285 and 340 nm were determ ined. Resu lts are shown in Table 3 . 2 .  6A% values between 
2 .4- 1 2 . 8  % were obta ined at 340 nm, and behveen 1 .6-30.07 % were obtained at 255  nm, and 
2 .99- 1 9 . 1 4  % were obta ined at 225 nm.  However, s ince most of these i nterferants can be 
e l im inated during DNA puri fication a good select iv i ty exists in deve loped interact ion 
between ABT and ct-DNA at 340 nm . The bands at 225/255  were s ign i ficantly a ffected by 
interference substances. 
AzBTS + ct·DNA (1 Oppm) +200 ul  of 1 0-7 M mterfenng agents 
0 5  
� "'" , ,'''''' I 
-- with alanine 
'" D 
« 
0 4  
0 3  
0 2  
0 1  
O W+------------------------------� ��� 
200 250 300 350 400 
Wavelength In nm 
I 
__ With CaCI2 
-- with CdCI2 
- With CoCI2 
I ---- With CuS04 
-I- With FeS04 
- wi th GlYCine 
- With HgCI2 
� With L-Valine 
__ with Pb(N03)2 
E
�·M�� 
-- with ZnCI2 I 
Fig .  3 .2 .6 .  Absorpt ion spectra obta ined by adding 1 .0 m l  of ct-DNA (20 j.lg/m l )  to 1 .0 m l  (20 
j.lglm l )  A BTS and 200 )ll ( 1 0-7 M) of interfering agents i n  phosphate buffer pH 7 .  
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Table .  3 .2 .  E ffects of some interfering sol utions on A BTS-ctDNA interca lates in phosphate 
buffer pH 7 .  A 1 0-7 M interfering solut ions were used 
I n terferi n g  
Con e. MolelL M% 
Age n ts 
225 n m  255 o m  340 o m  
A lan ine 6 .67 x 1 0.9 - 1 3 . 06 - 1 1 . 39  - 1 2 . 5  
CaCI2 6 .67 1 0-\1 2 .99 1 . 6 - 1 2 . 8  
CdCb 6.67 x 1 0-\1 -9.96 -8  -8 . 59  
CoCI2 6.67 x 1 0·\1 - 1 1 .08 -9 .54 -9 .09 
Cu 04 6 .67 x 1 0-\1 1 9. 1 4  30 .07 1 0 .0 
Fe 04 6.67 x 1 0-
\1 1 4 .50 1 4 .93 2 .44 
G lycine 6.67 x 1 0-\1 -9.45 -9 .27  - 1 0 .32 
HgCI2 6 .67 x 1 0-\1 1 2 .60 - 1 9 .45 -8 .94 
D-L-Va l i ne 6.67 x 1 0-\1 -7.05 -2 .68 -6.20 
MnS04 6 .67 x 1 0-\1 5 . 1 7  -6 . 7 1 -9 .56 
Pb(N03)2 6 .67 x 1 0·\1 4 . 54 1 1 . 0 1  -5 .6  
Zn(CI)2 6 .67 x 1 0-\1 -8 .92 -8 .97 -9 .85 
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3.3. Binding ite a n d  A ociat ion Con ta n ts 
Fig . 3 . 3 .  hows the b ind ing curves a t  260, 285 ,  290  and  340  nm for synthetic ssDNA 
(DI I ,  C5), D A ( D I 2, 6), dsDNA ( DwDI2, C5- 6) and ct-DNA with S- iodo-2 ' ­
deoxyurid ine (F igs. 3 . 3a l -3 .3a3), levofloxacin (F igs. 3 . 3 . b l -3 . 3b4), A BTS (F igs .  3 . 3 . c l -
3 . 3 .c4) and ri fampic in  ( F igs. 3 . 3 .d 1 -3 . 3  .d4) as defined by equat ion 1 .  The assoc iat ion 
constant (K) to the complexes and number of b ind ing sites on a nuc leotide res idue (n)  for 
synthet ic ssD A and dsDNA as wel l  as for ct-DNA were estimated from the s lopes and 
intercept and g iven i n  Tab les 3 . 3 . 1 -3 . 3 .4 [ 1 1 4- J  I S ] .  Considering the 260 nm absorpt ion 
band, assoc iation constants i n  the range of I x 1 04 -7x I 0
5 
were obta i ned for the ssDNA, 
dsD A,  and ct-DNA interca lates wi th  the  four compounds under i nvest igat ion .  At the  2 85 ,  
290 and 340  nm band assoc iation constants in  the range of I x l  04 -7x  1 05 were genera l l y  
obtai ned . Us ing molar concentrations of  1 . 88x 1 0.
5 J . 85x I 0.5, 1 .22x 1 0-5 6 .06x 1 0-
6 
for 
ssD A ( D I ) , ssD A ( D I 2), ssD A (C5), ssDNA (C6), dsDNA (D I I -D I 2) ,  dsDNA (C5-C6) 
and ct-DNA, b ind ing s i tes in the ranges of 0.05-2 .85 ,  0 .6 1 -3 .30,  0.003 -0.3 7, 0.02- 1 . 54  were 
respect ively obtai ned for S - iodo-2 ' -deoxyurid i ne, Levofloxac in ,  A BTS, and R i fampic in .  
Such variations cou ld  be attr ibuted to  changes in  b ind ing curves' s lopes and intercepts as wel l  
as to the complexi ty of DNA molecu les. 
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!lndlOg curve for 011 Vs 5-1odo·2' -deoxyuridine (10 ppm, pHI, 260 nm) 
1 06  l I Binding curve of 011 Vs 51Odo-2'-deoxyuridine (10ppm, pH7,285 nm) I 1 8 ,...------
0 97 
�0 88 � 
0 79 Y = ·30599x + 0 9282 
R2 = 0 9284 
0 1 �----------------�------� 
o EtOO 1 E-ll6 W)6 3 E-06 U.Q6 51·06 6 E.Q6 
�I-A1Ao)' C 
( 1 )  
1 6 
1 4  
y = -80283x + 1 0755 
R2 = 0.0072 
0 8 �----,-----�--,--,�-,--, 
-8 E.Q6 .7 E-06 " E.()6 ·5 E.Q6 .. o H.Q6 ·3 E.()6 .2 E.Q6 ·1 E.Q6 0 EIOO 
�1 ·A1.bil)C 
( I I ) 
Fig. 3 .3 .a l .  B inding curves for synthetic ssDNA ( 0 ] ] )  with 5 - iodo-2 ' -deoxyurid ine at 260 
nm (1) and 285 nm ( I I ) . Plotted curves are based on equat ion 2.  
Binding curve for ds(01 1 ,01 2) 'IS 5�odo ( 1  o ppm ,pH7 , 260 nm) 
0 93 j 
y = 36207x + 0 9422 






0 75 �----------�----�----.-� 
·5 E-06 -4 E-06 ·3 E-06 ·2 E-06 ·5 E-07 
-(1 ·NAo) 'C 
( J )  
Binding curve for ds(01 1 ,01 2) vs 5 ·iodo (10ppm, pH7, 285 nm) 
1 7 
1 5  
� o 
« 1 3  
y = -76191 x + 1 .0669 
1 1  R2 = 0.9983 I 0 9  +------.---,..---� I ·9 E·06 ·7 E·06 ·S.E.Q6 ·3 E·06 -(1 ·NAo) ' C ·1 .E-06 l _ - ------------' 
( I I )  
Fig. 3 .3 .a2. B ind ing curves for synthetic dsDNA (DWDI2 )  with 5 - iodo-2 ' -deoxyurid ine  at 
260 nm ( 1 )  and 285  nm ( I I ) . Plotted curves are based on equation 2 .  
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Binding curve lor ct·� vs S-iodo ( 10ppm,pH7, 260 nm) 
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Re wll and Discus ion!. peclrophotometry 
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Fig .  3 . 3 .a3.  B ind ing curves for ct-ONA with 5- iodo-2 ' -deoxyur id ine  at 260 n m  ( I )  and 285  
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Bnding curve for 01 1 Vs Levofloxacin (10 ppm, pH7, 260 nm) 
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8.E-05 
Fig .  3 . 3 . b ' - B i nd ing curves for synthet ic ssDNA (D I I )  wi th  levofloxac i n  at 260 nm ( I )  and 
290 nm ( I J ) .  P lotted cu rves are based on equat ion 2. 
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Binding curve of 01 2 Vs Levofloxacin (10ppm, pH7, 290 nm) 
y = -4048 .4x + 0 .4555 
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F ig .  3 .3 .b2 .  B ind ing curves for synthetic ssONA (0 1 2 )  with levofloxac in  at 260 n m  ( 1 )  and 
290 nm ( I I ) .  P lotted curves are based on equation 2 .  
Binding curve for dsl01 1 ,012) Vs levofloxacin (10 ppm, pH7, 260 nm) 
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F ig .  3 .3 . b3 .  B i nd ing curves for synthetic dsONA ( O l l -Od wi th  levofloxacin at 260  nm ( 1 )  
and 290 nm ( I I ) .  Plotted curves are based o n  equation 2 .  
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Binding curve for ct-DNA Vs levofioxacin (10 ppm, pff7, 260 nm) Binding curve of cl·DNA Vs Levofloxacin (1 Oppm, pH7, 290 nm) 
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0 9  
y = ·24885x + 0.8783 
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0 42 Y = -4090Ax + 0.4575 
<to 0 8  
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( J )  ( I I )  
Fig. 3 . 3 .b4 .  B ind ing curves for synthet ic  ct-DNA with Levotloxacin  at 260 n m  ( 1 )  and 290 
nm ( I I ) .  P lotted curves are based on equat ion 2 .  
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Fig.  3 . 3 . c l .  B ind ing curves for synthet i c  ssDNA (Cs) with A BTS at 260 nm ( I )  and 340 nm 
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Binding curve of C6 Vs ABTS (20ppm, pH7, 340 nm) 
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F ig .  3 . 3 .c2 .  B ind ing curves for synthetic ssDNA (C6) with A BTS at 260 n m  ( I )  and 340 nm 
( I I ) .  Plotted curves are based on equat ion 2.  
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2 55 Y = -219457x + 0.9565 
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-(1-AlAo) ' C ·1 (AlAo) ' C 
( 1 )  ( I J )  
F ig .  3 . 3 .c3 .  B ind ing  curves for synthet ic  dsDNA (CS-C6) with A BTS at 260 n m  ( 1 )  and 340 
nm ( 1 1 ) .  Plotted curves are based on equat ion 2.  
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Binding curve for ct-OO Vs ABTS (20 ppm, pH7, 260 nm) 
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Binding curve of ct-OO Vs ABTS (20ppm, pH7, 340 nm) 
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L 
( 1 ] ) 
Fig .  3 . 3 _c4 _ B ind ing curves for synthet ic ct-DNA with A BTS at 260 nm (1) and 340 nm ( I I ) .  
P lotted curves are based o n  equat ion 2 _  
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Binding curve for C5 Vs Rifampicin ( 10  ppm, pH7, 260 nm) 
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Binding curve of C5 Vs Rifampicin (1 0ppm, pH7, 475 nm) 
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Fig_  3 .3 _d I .  B ind ing  curves for synthetic ssDNA (Cs) with ri fampic i n  a t  260 nm ( J )  and 475  
nm ( J I ) _  P lotted curves are based on  equat ion 2 _  
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r---- -- - -I Binding curve for C6 Vs Rifampicin (1 0 ppm, pH7, 260 nm) 
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Binding curve of C6 Vs Rifam picin (1 0ppm, pH7, 475 nm) 
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Fig.  3 . 3 .d2 .  B ind ing curves for synthetic ssDNA (C6) with ri fampic in  at 260 n m  ( 1 )  and 475 




Binding curve for ds(C5,C6) Vs Rifam�cin (10 ppm, pH7, 260 nm) 
-1 '--- - - --
I Binding curve of ds(C5,CS) Vs Rifampicin (1 0ppm, pH7, 475 nm) 
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Fig.  3 . 3 . d3 .  B ind ing  curves for synthet ic  dsDNA (CS-C6) with r ifampic in  at 260 n m  ( I )  and 
475 nm ( 1 1 ) . P lotted cu rves are based on equation 2 .  
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Binding curve fOf ct·DNA Vs Rifampicin ( 10 ppm, pH7, 260 nm) 
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F ig .  3 . 3 .d4 .  B ind ing curves for synthetic ct-DNA with ri fampic in  at 260 n m  ( I )  and 475 nm 
( 1 1 ) _ Plotted curves are based on equation 2 .  
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e.  3 . 3 . 1 .  B ind ing curves' s lopes (K), intercepts, corre lation coefficients ( R2), number of binding si tes (n)  
i near equat ions at  260 and 285  nm for the interaction between DNA and 5- iodo 2 '-deoxyurid ine .  
c leic acid+ Am ax 
iodo (pH 7) 
conc. K 
0 1 1 260 1 . 8 8E-05 3 .05 x 1 04 
0 1 1 285  1 . 8 8E-05 8 .02 x 1 04 
( 0 1 1 ,0 1 2) 260 1 . 88 E-05 3 .62 x 1 04 
( D l 1 ,D I 2) 285  1 . 88E-05 7 .6 1 x 1 04 
ct-ONA 260 1 . 8 8E-05 5 .67 x 1 04 










0.93 0. 1 3  Y= -3 .05X +0.92 
1 .00 0 . 05 Y= -8 .02X + 1 .07 
0.98 2 . 85 Y= 3 .62X + 0.94 
1 .00 0 . 05 Y= -7 .6 1 X  + 1 .06 
0 .99 0 .05  Y= -5 .65X + 1 . 04 
0 .89 1 . 1 3  Y= - 1 2 . 3X + 0.73 
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e. 3 .3 . 2 .  B ind ing curves' s lopes (K), intercepts corre lation coeffic ients ( R2), number of b ind ing s i tes (n)  
l inear equat ions at  260 and 290 nm for the interaction between ONA and levofloxac in .  
c le ic acid+ 
Amax conc. K intercept R2 n Equation 
evo (pH 7) 
O I l 260 1 . 8SE-OS 2.32 x 1 0  0.86 0.9S 0.99 Y= -2 .32X + 0.86 
0 1 1 290 1 . 8 SE-OS 3 . 2 1 x 1 04 0.4 1 0.90 3 .00 Y = -3 .2 I X  + 0.4 1 
0 1 2  260 1 . 8 SE-OS 2 . 70 x 1 04 0 .89 0 .96 0.6 1 Y = -2.70X + 0.89 
0 1 2  290 1 . 8S E-OS 4 .04 x 1 0
4 O .4S 0.90 2 .2 1 Y = -4.04X + O.4S 
( 0 1 1 , 0 1 2) 260 1 . 8S E-OS 1 . 79 x 1 0
4 0 .80 0 .92 1 . 79 Y = - 1 .79X + 0.80 
( 0 1 1 ,0 1 2) 290 1 . 8S E-OS 2.97 x 1 04 0.40 0 .88  3 . 30  Y= -2 .97X + 0.40 
ct-ONA 260 1 . 8SE-OS 2 .48  x 1 04 0 .87 0.95 0 .80 Y= -2 .48X + 0 .87 
ct-O A 290 1 . 8SE-OS 4 .09 x 1 04 O .4S 0.9 1 2 . 1 8  Y= -4 .09X + O.4S 
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e. 3 . 3 . 3 .  B inding curves' s lopes (K), intercepts, corre lat ion coefficients ( R2), number of b ind ing sites (n) 
l i near equat ions at 260 and 340 nm for the interaction between DNA and ABTS 
c leic acid + 
R2 '-max cone. K intercept n Equation 
BT (pH 7) 
C5 260 1 .22E-05 4 . 1 6  x 1 0  0.89 0.90 0.20 y= -4 . 1 6X + 0 .89 
C5 340 1 . 22E-05 2 . 1 2  x 1 04 1 .00 0.99 0. 003 y= -2 . 1 2X + 1 .00 
C6 260 1 . 22E-05 4 .62 x 1 0
4 0.93 0.96 0. 1 1  y= -4.62X + 0.93 
C6 340 1 .22E-05 2 . 1 6  x 1 0
4 0.95 0.99 0 . 0 1  y =  -2. 1 6X + 0.95 
ds (C5,C6) 260 1 . 22E-05 4.43 x 1 0
4 0 .92 0.95 0. 1 3  Y= -4 .43X + 0.92 
ds (C5,C6) 340 1 .22E-05 2 . 1 9  x 1 0
4 0.95 0.99 0 . 0 1  Y= -2 . 1 9X + 0.95 
ct-D A 260 1 .22E-05 3 . 37  x 1 0
4 0 .84 0.9 1 0 . 37 Y= -3 .37X+ 0.84 
ct-D A 340 I . 22E-05 2 .22 x 1 0
4 0.92 0.99 0.02 Y= -2.22X + 092 
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e. 3 . 3 . 4 .  B i nd ing cur es' s lopes (K), intercepts, corre lat ion coeffic ients ( R2), number of b inding s i tes (n) 
l inear equat ions at 260 and 475 nm for the interact ion between DNA and r ifampic in 
c le ic ac id + 
Ama conc. K intercept R2 n equation 
if a (pH 7) 
CS 260 6.08E-06 1 .49 x 1 0  1 .0 1  0 .95 0 . 0 1  y= - 1 .49X + 1 .0 1  
C5 475 6.08E-06 3 .0 1 x 1 05 1 .05 1 .00 0 . 03 y= -3.0 1 X + 1 .05 
C6 260 6.08E-06 2 . 82 x 1 05 0 .99 0 .87 0 . 04 y= -2 .82X + 0 .99 
C6 475 6.08 E-06 2 . 77 x 1 05 1 .03 1 . 0 0 . 02 y= -2 .77X + 1 .00 
ds(CS ,C6) 260 6.08E-06 1 . 84 x 1 05 1 .02 0 .98 0 . 03 y= - 1 . 8SX + 1 .02 
ds(C5 ,C6) 475 6 .08E-06 2 . 36  x 1 05 1 .03 0.98 0.02 y= -2 .36X + 1 .03 
ct-D A 260 6.08E-06 7 .S 1 x 1 05 0.93 0.95 0 . 1 5  Y= -7. 5 I X + 0.93 
ct-D A 475 6.08E-06 6.50 x 1 0
5 0 .39 0 .87 1 . 54 y= -6.S0X + 0.39 
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3.4. Di cu ion o f l n te raction Mec h a n ism 
Resulls and Discussion/Spectrophotomelly 
I n  est igated drugs and compounds have proved to bind nuc le ic  acids in  e lectrostat ic  
and i n terca lat ion \ ay in to the major and the m inor grooves. Structure p lanarity and non­
negati e charge are the t\ 0 i ta l  factors requ i red for an efficient i ntercalat ive mechanism 
[45 ] .  I t  seems that  5- iodo-2 -deo yurid i ne, levofloxac in  and r ifampic in  have proven the two 
features with d i fferent extents. Quench i ng the absorption in tens i ty at the i r  respect i ve "max is 
an evidence of  interca lat i ng these drugs into the stack ing base pairs of nuc le ic  acids [46] .  
Therefore the b ind ing of our i nvest igated drugs with nucleic acids can be assumed to occur in  
an interca lation mode. A BTS i n  i ts reduced foml is negat ively charged . Therefore, a groove 
b ind ing or interca l at ion mechanisms m ight be suggested for i ts  i nteraction with i nvest igated 
ssD A and dsD A .  
3.5.  A n alysis o f  Sy n t h etic a nd Real Sa m ples 
Detenn i nation of DNAs in  extracts from ca lf  thymus and human blood US ing the 
cal ibrat ion graph for synthetic DNA (Table 3 . 5 . ) .  Recoveries% of 93 .33- 1 06.60 were 
respect iye ly obta ined for natura l  ca l f  thymus and human DNAs using 5 - iodo-2 ' ­
deoxyurid i ne, levofloxac in ,  A BTS and r ifampic in  respect ive ly .  These recoveries refl ected 
re lative standard deviat ions in the range of (2-3 . 33) .Th i s  revea l s  c learly that the proposed 
methods are re l iable s imple, and pract icable .  
79 
Chapter 3 Re u/IS and Discussion/Spectrophotometry 
Ie .  3 . 4 .  Detenn i nation resu lts of ct-DNA and human DNA samples based on the 260, 285 ,  290 340 
bands using the ca l i brat ion curves from synthet ic  dsDNA. 
ucleic ac i d  Concentrat ion ( /-lg/mJ)  Found ( /-lg/ml)
a 
a) Using 5 - iodo-2 ' -deoxyurid ine as probing spec ies 
ynthet ic dsDNA 3 .00 3 .20 
5 .00 5 . 1 0  
Ct-D A 3 .00 2 .95 
H uman DNA 3 .00 2 .80 
b) Using levotlo acin as probing species 
S nthetic dsDN A  3 .00 3 . 1 0  
Ct-D A 3 .00 2 .95 
H uman DNA 3 .00 2 .90 
c) Using ABT as probing species 
Synthetic dsDNA 3 .00 3 1 0  
5 .00 4 .90 
Ct-D A 3 .00 3 . 1 0  
Human DNA 3 .00 2 .90 
d) Using as r i fampic in  as probing spec ies 
Synthetic dsDN A  3 .00 2 .90 
5 .00 5 . 1 0  
Ct-DNA 3 .00 3 . 1 0  
H uman DNA 3 .00 2 .80  
Recovery% R.S .D 
1 06.60 3 .33% 
1 02 .00 2% 
98 .30 2 .67% 
93 .33  3 .33% 
] 03 .33  3 . 33% 
98.30 3 . 3 3% 
96.67 3 .3 3% 
1 03 . 33  3 . 33% 
98.00 2% 
1 03 . 33  3 .33% 
96.67 3 . 33% 
96.67 3 . 33% 
1 02 . 00 2% 
] 03 . 33  3 . 33% 
93 .33  3 .33% 
elat ive standard deviations (RSD) are based on  the average of  at least three detenninations. 
80 
hapter 3 Results and Discussion/Spectrophotometry 
3.6.  Conclu ions 
In phosphate buffer pH 7 ssDNA, dsDNA with 20 and 40 base pai rs as wel l as ct-DNA 
and human D A ha e shown to react with 5 - iodo-2 ' -deoxyurid i ne, levofloxac in ,  ABTS and 
ri fampicin,  respect ivel  at  room temperature resu l t ing in decreas ing the absorption intens it ies 
at 285,  290, 340 and 475 nm.  L inear ca l i brat ion graphs for synthet ic ssDNA, dsDNA as wel l 
as ct-DNA in the range of J -7 Ilg/m l were obta ined. DNA in extract ion products from ca lf  
thymus and human blood was tested us ing the  ca l ibration graph for synthet i c  DNA and 
sat isfactory recoveries were obta i ned. The association constant and number of b ind ing s i tes 
on s nthet ic ssDNA and dsDNA as wel l  as ct-DNA were est imated using the Rosenthal ' s 
graph ical method. 
New Spectrophotometric methods for determ in ing natura l  ca lf  thymus and human 
DNAs based on interca lates with 5 - iodo-2 -deoxyurid ine, levofloxac in ,  A BTS and 
ri fampic in ,  respect ively were developed . Developed methods have shown good re l iab i l i ty, 
sensi t iv ity, rap id i ty and reproduc ib i l i ty when appl ied for determ in ing nuc le ic  ac ids i n  
synthet ic  and  b iochem ical samples.  
An i nterca lat ion interact ion mechan ism was proposed for the b ind ing mode of ssDNA,  
dsD A ,  ct-D A ,  and human D A w i th  S - iodo-2 ' -deoxyuridi ne, levofloxac in and  r ifampic i n  
drugs.  A groove bind ing o r  in tercalat ion mechanism m i ght be proposed for the invest igated 
DNA i nteract ion with A BTS. React ion of A BTS with ct-DNA has shown to be select i ve 
i nterference from cations and amino acids was tested and sat i sfactory resu l ts were obta ined .  
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RESUL T AND DISCUSSION 
Fluorimetry 
Chapter ..f Results and Discussion/Fluorimetry 
4. 1 .  F l u o re c e n ce S pectra of R i fa m p i c i n  
4. 1 . 1 .  C h a ra cterist ics o f  R i fa m p i c i n  F l u o resce n ce s pectra 
Exc itat ion spectra of r ifampic in in  phosphate buffer pH 7, showed three 
ab orpt ion bands at 235  335  and 475 nm.  The fl uorescence emission spectra of  
ri fampic in  gave an intense fluorescence emission bands a t  475 and 670 nm when 
measured at 235 and 3 3 5  nm as Amax of excitat ions i n  phosphate buffer pH 7,  
respect ive l  . ( F ig .  4 .  I .  I ) . 
500 ( I ) 












400 500 600 700 
Wavelength ( nm) 
Fig. 4 . 1 . 1 .  F l uorescence spectra of 1 .0 m l  of 5 Ilg/m l r ifampic in  in phosphate buffer 
pH 7 using exci tation of Amax 235  nm in ( I ) and 335  nm in ( I I  ) .  
I ntens i ty of  fl uorescence was measured a t  d i fferent r i fampic in's concentrat ions. 
Fig. 4 .  I .2. shows the variat ion of fluorescence intensi ty at the two em ission Amax 475 
(F ig .  4 . 1 .2a) and 670 nm ( Fig .  4 . 1 .2b) us ing 5 ,  1 0, 1 5 , 20 ,  30 and 5 0  Ilg/m I r ifampic in  
sol ut ions. The figures show that the i ntensity of fl uorescence decreases wi th  
increasing ri fampic in  concentrat ion with max imum emIss Ion intensi t ies at 
concentrat ions of 5 - 1 0  Ilglm l .  The reason can be attr i buted to se l f  quench ing and/or 
se l f  absorpt ion processes.  Therefore, an opt imum concentrat ion of 5 - 1  ° Ilg/m l was 
se l ected and used through out the whole subsequent invest igat ions. 
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Effect  of Gonc . in ppm Rifa vs intens ity 
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450 E 400 c 
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Rifa Gonc . in ppm 
Fig. 4 . 1 .2a .  E ffect of concentration of ri fampic in on fluorescence i ntensity measured 
at 475 nm as "-max of em ission in  phosphate buffer pH 7 .  
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Fig.  4 . 1 .2b .  E ffect of concentrat ion of r ifampic in  on fluorescence intensity measured 
at 670 nm as "-max of em ission in  phosphate buffer pH 7. 
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4 .1.2. I n teract ion between DNA a n d  R i fa m pic in  
Addit ion of  nucle ic acids to r i fampicin solut ion in  phosphate buffer pH 7 was 
hown to decrease the fluorescence intensi t ies of ri fampic in  at both emission bands 
475 and 670 nm. The reason can be attributed to the interca lat ion of r i fampic in in  
major groo es of DNA .  F igs. 4 .  I . 2a-f show the fluorescence spectra obtai ned by 
succes i e add i t ions of ct-DNA to ri fampic in at d i fferent concentrat ions in phosphate 
bu ffer pH 7. There fore, A lthough th is  drug is act ing as ant ib iotic, i t  may a lso have 
inh ib i tory e ffects on DNA synthesis of m icroorgan isms.  The drug can a l so serve as a 
probe for nuc le ic  ac ids determ inat ions by fo l lowing the decrease i n  fluorescence 
intensity. 
( I ) 
500 





£ (/) 4 c 
2 200 c 
1 00 
o��==�--���---------.----�����---------, 
400 500 600 
Wavelength ( n m) 
700 
Fig. 4 . 1 .2a .  F luorescence spectra obtai ned by successive add i t ions of 200, 600, 1 000 
fll  port ions of 5 flg/m l ct-DNA to 1 .0 m l  of 5 flg/m l ri fampic in  in  phosphate buffer p H  
7 .  The spectra were measured a t  235  nm a s  "'max o f  exc itat ion in  ( ] ) and a t  3 3 5  nm as 
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Wavelength ( nm) 
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Fig. 4 .  J .2b .  F luorescence spectra obta ined by successive addit ions of 200, 600, 1 000 
III port ions of 1 0  )lg/m l ct-DNA to 1 .0 ml of 1 0  )lg/m l r ifampic in  in phosphate buffer 
pH 7. The spectra were measured at 235  nm as Amax of exc i tat ion i n  ( I ) and at 335  nm 
as Amax of exc i tation in ( IJ ) . 
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Fig. 4 . 1 .2c .  F luorescence spectra obta ined by successive addit ions of 200, 600, 1 000 
III port ions of I S  )lg/m l ct-DNA to 1 .0 ml of 1 5  )lg/m l ri fampic in  in phosphate buffer 
pH 7. The spectra were measured at 2 3 5  nm as Amax of exc i tat ion i n  ( I )  and at 335  nm 
as Amax of exc itation in  ( Il ) . 
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Fig. 4 . 1 . 2d .  F luorescence spectra obta ined by successive add i t ions  of 200, 600, 1 000 
�!l port ions of 20  I-lg/m l ct-DNA to 1 .0 ml 0[ 20  I-lg/m l r i fampic in  in phosphate buffer 
pH 7. The spectra were measured at 235  nm as Amax of exc itat ion in ( J )  and at 3 3 5  nm 
as Amax of exc itation i n  ( 1 1  ) .  
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Fig. 4 . 1 .2e .  F l uorescence spectra obtai ned by success ive add i t ions of 200, 600, 1 000 
I-li port ions of 30 I-lglm l ct-DNA to 1 . 0 ml of 30 I-lg/m l ri fampic in  in phosphate buffer 
pH 7. The spectra were measured at 235  nm as )cmax of exc itat ion in ( ] ) and at 335  nm 
as Ama, of exci tat ion in  ( ] ]  ) .  
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Fig. 4 . 1 . 2f. F luorescence spectra obta ined by success ive add i t ions of 200, 600, 1 000 
III port ions of  50 Ilg/m J ct-DNA to 1 .0 ml of 50 Ilglm l r i fampic in  in  phosphate buffer 
pH 7. The spectra were measured at 235  nm as "-max of exci tat ion i n  ( I ) and at 3 3 5  nm 
as Amax of exc i tat ion in ( I I  ) .  
4. 1 .3 .  O ptimization o f  Reaction Conditions. 
4. 1 .3. 1 .  Effect of pH 
E ffect  of pH on fluorescence intensity of r ifampic in  was investigated i n  
phosphate buffers pH 4-7 us i ng  1 0  and  50 Il.glm l r i fampic in  (F igs .  4 . 1 . 3 . 1 a-f) .  
F l uorescence intensit ies us ing 5 0  )lglm l r ifampic in  ( F igs 4 .3 . 1  a-c) are aga in  
sign i ficant ly less  than us ing 1 0  )lglm l ri fampic in  ( F igs 4 . 1 . 3 . 1 d- t) .  The reason can 
aga in  be attr i buted to se l f  q uench i ng and/or se l f  absorpt ion processes. Figs .  4 . ) . 3 . ) g-h 
show the effect of pH on fl uorescence intens i ty of 1 0  and 50 /-lglm l r ifampic in  at 475 
and 670 n m  em ission Ama measured at  235  nm as "-max and 3 3 5  nm as "-max of 
exci tations i n  ( I )  and ( I I ) ,  respect i ve ly .  The h ighest fluorescence i ntens i t ies were 
obta i ned in the pH range 5 and 7. S i nce ssDNA and dsDNA molecu les are more 
stab le at pH 7, phosphate bu ffer pH 7 was used for a l l  subsequent measurements. 
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Fig.  4 . 1 . 3 . 1  a .  F l uorescence spectra obta i ned by success ive add it ions of 200, 600, 1 000 
III port ions of 1 0  Jlg/m l ct-DNA to 1 .0 m l  of 1 0  Jlg/m I ri fampic in  in phosphate bu ffer 
pH 4. The spectra were measured at 235  nm as Amax of exc i tation i n  ( I ) and at 3 3 5  nm 
as Amax of exc i tat ion i n  ( I I  ) . 
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Fig .  4 . 1 .3 . 1  b. F l uorescence spectra obta ined by successive add i t ions of 200, 600, 1 000 
JlI port ions of 1 0  Jlg/m l ct-DNA to 1 .0 m l  of 1 0  Jlg/m l ri fampic in  in phosphate buffer 
pH 5 .  The spectra were measured at 235  nm as Amax of excitation in ( I ) and at 3 3 5  nm 
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Fig. 4 . 1 . 3 . 1 c .  F luorescence spectra obtai ned by successive add i tions of 200, 600, 1 000 
!ll portions of 1 0  f.lg/m l ct-DNA to 1 .0 m l  of 1 0  f.lglm l ri fampic in  in phosphate buffer 
pH 6. The spectra were measured at 235  nm as A.max of excitation i n  ( I ) and at 335  nm 
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Fig. 4 . 1 .3 . 1 d. F l uorescence spectra obta ined by success ive add i t ions of200, 600, 1 000 
f.ll port ions of 50 f.lglm l ct-DNA to 1 .0 m l  of 50 f.lglm l r i fampic in  in phosphate buffer 
pH 4 .  The spectra were m easured at 235  nm as A.max of exc itation i n  ( I ) and at 3 3 5  nm 
as A.max of exci tat ion i n  ( I l  ) . 
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Fig .  4 . 1 . 3 . 1  e. F luorescence spectra obta i ned by success ive add i t ions 0[ 200 600, 1 000 
I-ll port ions of 50 I-lg/m l ct-DNA to 1 . 0 ml of 50 I-lg/m l ri fampic in  in phosphate buffer 
pH 5 .  The spectra were measured at 235  nm as Amax of excitat ion i n  ( I ) and at 335  nm 
as Amax of exc itation in ( I I  ) . 
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Fig. 4 . 1 .3 . 1 f. F l uorescence spectra obta i ned by success ive add i t ions of 200, 600 1 000 
I-ll port ions of 50 I-lg/m l ct-DNA to 1 .0 m l  of 50 l-lg/m J ri fampic in in phosphate buffer 
pH 6. The spectra were measured at 235  nm as Amax of exc i tat ion in ( I ) and at 335  nm 
as Amax of exc i tat ion i n  ( I I  ) . 
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Fig.  4 . 1 .3 . 1 g . Effect of  pH o n  fluorescence intensity o f  1 0  )lglm l ri fampic in at 475 
and 670 nm emission Ama measured at 235 nm as Amax and 335  n m  as A,max of 
exci tations in ( 1 )  and ( I I ) , respect ively, 
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4. 1.3. 2. Reaction Time and Stability 
The binding i nteraction of nucleic ac ids with r ifampic in was found to be 
completed in l ess than I min  at room temperature. Decrease in  fluorescence intens i ty 
cau ed by the add i t ion of nucleic ac ids remained constant for 30 m in  at room 
tem peratu re.  This reflects the rapid i ty of the interca lation process and the possibi l i ty 
of using r i fampic i n  as probe in deve loping methods for nucle ic ac id determ inat ion.  
However, react ion t imes � 5 .0 minutes were prev iously reported [ 1 1 6] .  
4. 1 .3. 3. A ddition Order oJ Reagents 
The addi t ion order of  reagents was found to hard ly  have i nfluence the 
fluorescence in tens ity of investigated nucleic ac ids - ri fampic in  i nterca lates. 
4. 1.3. 4. A nalytical characteristics: dynamic range and sensitivity 
Under the opt imum condi t ions g iven above, ca l i brat ion graphs were constructed 
by add i ng success ive amounts of ct-DNA ( 1 0  or 50 �g/m l )  to 1 .0 m l  ( 1 0  or 50 �g/m l 
ri fampic in )  in phosphate buffer p H  7. F l uorescence intens i t ies were measured at the 
wave lengths  of max im u m  emiss ion 475 and 670 nm using 2 3 5  and 3 3 5  nm as A.max of 
exc i tat ion .  F igs. 4 . 1 . 3 .2a-b shows straight l i nes ca l i brat ion graphs in  the range 1 . 5 -5 
�g/m l DNA .  The analyt ical parameters of obtai ned cal ibrat ion curves are l i sted in  
Tab le  4 .  I . 3 .4 
Table .  4 . 1 . 3 .4 L inear ranges regression equat ions, detection l i m i ts and corre lation 
coefficients characterist ics for ct-DNA ca l i brat ion graphs using 5 /-lg/ml ri fampic in .  
Linear ranges L inear regression Detection l imits
a 
R2 ucleic acid slope 
(�g/m l )  equat ions (/-lglml ) 
475 nm 1 .6-5 Y=4 . 1 8X+35 . 932 0 .79 4 . 1 8  0 .99 
670 nm 1 .6-5 Y= 1 .49X+ I O .532 1 .22 1 .49 0 .9 1 
Reported va l ues are for ca l ibrat ion graphs at 475 nm and 670 nm .  
a 
Detect ion l i m i t s  were ca lcu lated us ing (3as)IR where as is t he  standard deviat ion of  t he  
b lank 
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Fig.  4 . 1 . 3 . 4a. Cal i bration curves of ct-DNA uS ing 5 ,  1 0, 1 5 , 20, 30  and 50 ppm 
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Fig .  4 . 1 .3 .4b.  Cal i brat ion curves of ct-DNA using 5, 1 0, 1 5 , 20, 30 and 50 ppm 
Rifampic in  at 670 nm and pH 7 .  
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4. 1.3. 5. Analy is of Real samples 
De e loped methods were appl ied to the detenn ination of DNAs extracts from 
ca l f  thymus using the ca l i brat ion graph given in  Figs. 4 . 1 . 3 .4 .  Recovery% of 92 .53 -
1 09.92 was obta ined . 
4. 1.3. 6. Binding Sites and Association Constants 
Figs. 4 . 1 . 3 .6 .(a-f) show the b ind ing curves at ca 475 and 670 nm for ct-DNA 
with r ifampic in as defined by equation 2. The associat ion constants (K) to the drug 
and number of b ind ing si tes on a nuc leot ide residue (n) were est imated from the 
s lopes and i ntercepts and g iven in  Table 4 . 1 . 3 .6  [ 1 1 4- 1  1 5 ] .  Considering the 465 nm 
fluorescence band, associat ion constants in  the range of  1 . S-4 .0x 1 04 were obtai ned 
using d i fferent r i fampic in  concentrations. At  the 670 nm band, assoc iat ion constants 
in the range of 0.4-2 .9x 1 04 were genera l ly obta ined. Us ing molar concentrations of  
1 . 82x I O-5 b ind ing s i tes i n  the ranges of 0.02-4 .0 1  and 0.07-0.42 were respect ively 
obtai ned (Table 4 . ] . 3 .6) .  Such variat ions cou ld be attr i buted to changes in  b ind ing 
curves' s lopes and in tercepts as  wel l  as  to the comp lexi ty of DNA molecu l es .  
4. 1 .3. 7. Discussion of Interaction Mechanism 
Quench ing of fluorescence i s  an evidence of interca lat ing the complex probes 
into the stack ing base pairs of nucle ic ac ids [46] . There fore the b ind ing of our 
invest igated complex with nucle ic ac ids can be assumed to occur in an i nterca lat ion 
way. R i fampic in has shown to bind nucle ic ac ids in  intercalat ion ways. Structure 
planari ty and non-negat i ve charge are the two factors that fu l fi l led for ri fampic in  as 
an effic ient i ntercal at i ve probe [45 J . 
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Binding curve for Rifa vs cl·DNA (5ppm, pH7, 475 nm) Binding curve for Rifa vs ct.oNA (5ppm, pH7, 670 nm) 
1 1  1 2  
y = -39991 X + 0.9803 y = -42128x + 0.986 
R2 = 0.9497 R
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= 0.9358 
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-{l.fIFo) ' C -{l.flFo), C 
( 1 )  ( I I )  
F ig .  4 . 1 .3 .6a.  B ind ing curves for ct-DNA wi th 5 ppm R i fampic in a t  475 n m  ( ] )  and 
670 nm in  ( 1 1 ) . P lotted curves are based on equation 2 .  
0 8  
Binding curve for Rifa v s  cl·DNA (10ppm, pH7, 475 nm) 
y = ·36069x + 0.9708 
R2 = 0.927 
0 6 �---------r-----.,----------­
O E+oo 2 E-06 S E.lJ6 8 E-OS 
-{l.flFo) ' C 
( 1 )  
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F ig .  4 . 1 . 3 .6b.  B ind ing curves for ct-DNA with 1 0  ppm R i fampic in  at 475 n m  ( I )  and 
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Binding curve for Rifa vs cl-DNA (lSppm, pH7, 670 nm) 
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F ig .  4 . 1 . 3 . 6c .  B inding curves for ct-DNA with I S ppm R i fampic in at 475 n m  ( 1 )  and 
670 nm in ( 1 1 ) . P lotted curves are based on equation 2 .  
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Fig.  4 . 1 .3 .6d .  B ind ing curves for ct-DNA with 20 ppm R i fampic in  a t  4 7 5  nm ( I )  and 
670 nm in (n) .  P lotted curves are based on equation 2 .  
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binding curve for Rifa vs ct-DNA (30ppm, pH7, 670 nm) 
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F ig .  4 . J . 3 . 6e .  B ind ing curves for ct-ONA with 3 0  ppm R i fampic in  at 475 nm ( 1 )  and 
670 nm in ( I I ) . P lotted curves are based on equation 2 .  
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Fig .  4 . 1 .3 .6f. B ind ing curves for ct-ONA with 5 0  ppm R i fampic in  a t  4 7 5  nm ( 1 )  and 
670 nm in ( I I ) . Plotted curves are based on equation 2 .  
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able. 4 . 1 . 3 .6 . 1 .  B inding curves' slopes (K), i ntercepts, corre lation coeffic ients ( R2 ), number of 
inding si tes (n) and l inear equations at 470 nm for the interact ion between ct-DNA and R i fampic in 
t pH 7 .  
ct-DNA Cone. 
A.max K i n tercept R2 n E q u a t i o n  
Jlg/m l M oVI 
5 235  
1 . 82E-05 3 .99 x 1 04 0 .98 0 .94 0 .02 Y=-3 .99X + 0.98 
1 0  235  
1 . 82E-05 3 .60 x l 04 0.97 0 .92 0.04 Y= -3 .60X + 0.97 
] 5  235  
1 . 82E-05 3 . 1 6  x 1 04 0.95 0.9 1 0 .07 Y= -3 . 1 6X + 0 .95 
20 235  
1 . 82E-05 4 .02 x 1 04 0 .98 0.93 0 .02 Y= -4.02X+ 0.98 
30 235  
1 . 82E-05 2 . 38  x 1 04 0.93 0 .87 0 . 1 5  Y= -2 . 38X + 0.93 
50 235  
1 . 82E-05 1 . 52  x 1 04 0 .88 0 .8 1 0.40 Y= - 1 . 5 2X + 0.88 
able .  4 . 1 . 3 .6 .2 B ind ing curves' s lopes (K), intercepts corre lation coeffic ients ( R2), number of 
jnding sites (n) and l inear equations at 670 nm for the interact ion between ct-DNA and R i fampic in 
pH 7 .  
-DNA Conc.  
Amax K i n tercept R
2 n E q ua t i o n  
�g/m l m o lll 
5 335  
1 . 82E-05 3 . 2 1 x 1 04 0 .98 0 .93 0 . 1 8  Y=-4 .2 1X + 0.98 
1 0  335  
1 . 82E-05 2 .60 x 1 04 0.94 0 .89 0 . 1 3  Y= -2 .60X + 0.94 
1 5  335  
J . 82E-05 2 . 33  x 1 04 0.93 0 .89 0 . 1 6  Y= -2 .33X + 0.93 
20 335  
1 . 82E-05 2 .90 x 1 04 0 .96 0 .90 0.07 Y =  -2 .90X + 0.96 
30 335 
1 . 82E-05 2 . 1 4  x 1 04 0 .92 0 . 86 0 .70 Y= -2 .  1 4X + 0.92 
50 335  





>-.� (/) c 
2 c 
haptel ..f Results and Discussion/Fluorimetry 
4. 2. Fluorescence spectra of A B TS: 
4. 2. 1. Characteristic of A B TS Fluorescence spectra 
F luorescence em i  sion spectra of the reduced form of A BTS show intense 
fluorescence band around 465 680, and 780 nm us ing 230  340 and 390 nm as 
e c i tat ion wavelengths, respect ively ( F ig. 4 .2 . 1 a). Addit ion of nuc le ic  ac ids decreased 
the fl uorescence intens i t ies due to the i ntercalat ion of nuc le ic  acids with the A BTS. 
Figs. 4 .2a-e show the fluorescence spectra obta i ned by successive add i tions of 20 
)lg/m l ssD A (C5) ,  ssDNA (C6)' dsDNA (C5-C6)' ct-DN A and human DNA in  
phosphate buffer pH 7 .  
1 000 









( 1 1 1 )  
800 
Fig. 4 . 2 . 1 a. F l uorescence spectra obtai ned by success ive add i t ions  of 1 0  III port ions of  
C5 (20 Ilg/m l )  to  1 .0 ml  of ABTS (20 )lg/m l )  in  phosphate buffer pH 7 .  230, 340 and 
390 nm were used as exci tation wave lengths for the em ission bands of 465 nm in ( I ), 
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Fig. 4 . 2 . 1 b. F luorescence spectra obta ined by success ive add i t ions of 1 0  )ll port ions of  
C6 (20 )lg/m l)  to  1 .0 m l  of  ABTS (20 )lg/m l)  in  phosphate buffer pH 7 .  230, 340 and 
390 nm were used as exc i tation wavelengths for the emiss ion bands  of 465 nm in  ( I ) ,  
680 nm i n  ( 1 1 ) and 780 nm in  ( 1 I I  ) .  
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Fig. 4 . 2 . 1 c. Fl uorescence spectra obta ined by success ive add i t ions of 1 0  )l l port ions of  
CYC6 dsDNA (20 )lg/m l )  to  1 .0 m l  of A BTS (20 )lg/m l)  in  phosphate buffer pH 7 .  
230,  340 and 390 nm were used as exc itation wavelengths for the em iss ion bands of 
465 nm i n  ( I ), 680 nm in  ( I I  ), and 780 nm i n  ( l J l  ) .  
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Fig.  4 .2 . 1 d. F l uorescence spectra obta ined by success ive add i t ions of 1 0  ) ..t1 portions of 
ct-D A (20 )lg/m l )  to 1 .0 m l  of A BTS (20 )lglm l )  in  phosphate buffer pH 7. 230, 340 
and 390 nm were used as exc itation wavelengths for the emission bands of 465 nm in 
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Fig .  4 .2 . 1 e. F l uorescence spectra obta ined by successive add i t ions of 1 0  )ll port ions of 
human DNA (20 )lglm l )  to 1 .0 ml of A BTS (20 )lg/m l )  in  phosphate buffer pH 7 .  230, 
340 and 390 nm were used as exc itat ion wave lengths  for the emission bands of 465 




4. 2. 2. Optimization of reaction conditions. 
4.2. 2. 1. Reaction time and stability 
Results and Discus ionlFluorimetrv 
The b ind ing interact ion reaction of nuc leic acids with A BTS was found to be 
completed in l ess than I m in at room temperature. Decrease in fluorescence intensity 
caused b the addi t ion of nuc le ic  acids remained constant up to 4 8  hours .  Th i s  reflects 
the s imp l ic ity and rapid i ty of the intercalat ion react ion. However react ion t imes � 5 .0  
minute were previously reported [87 ] .  
4.2. 2. 2 Addition order of reagents 
The add i t ion order of  reagents was found to hard ly  have an i nfluence on the 
change of fl uorescence intens i ty of i nvest igated nucleic ac ids - A BTS interca lates. 
4. 2.2.3. A nalytical Characteristics: Dynamic Range, Sensitivity and Molar Ratio. 
Under the opt imum cond i t ions given above cal ibrat ion graphs for Cs , C6, 
ds(CS ,C6), and ct-DNA were constructed by p lott ing F versus nuc le ic  ac ids 
concentrat ions in  J.lglm l at 465, 680 and 780 nm ( F igs. 4 . 2 . 2 .3a-b). The ana l yt ica l  
parameters obta ined from these curves are l i sted in  Table 4 . 2 . 2 . 3  [4-6 I ] , 84 ,  87] .  
The molar rat ios of  nuc le ic  acids-ABTS intercalates were determ ined us ing the  molar 
rat io  method.  A 1 0  J.l1 successi ve amounts of 20 flg/m l CS ' C6, ds(CyC6)' ct-DNA, or 
human D A were added to 1 m l  of 20 J.lg/m l ABTS in phosphate buffer pH 7 .  P lots 
of fluorescence versus concentrat ion confi rmed I :  I mass rat i o  of  DNA :  A BTS 
4.2.2.4. A nalysis of Real samples 
ABTS was successfu J ly used for the determ ination of  DNAs using the 
ca l ibrat ion graphs given i n  F igs. 4 . 2 . 2 . 3 .  Recoveres% of 93 .00- 1 1 0 .00 were obtained.  
1 03 
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Cal ibration curvo of C5, C6, ds(C6,C6), and cl·DNA using AzBTS (20 ppm, pH 7, 466 n m )  
1200 I __ C5 + AzBTS ' 
1000 
BOO 




0 0 2  0 4 0 6  
Nucleic acid Conc. ug/ml 
0 8  1 2  
--- C6 + AzBTS 
- - ds(CS.C5) + 
AzBTS 
Fig. 4 .2 .2 .3a .  Ca l ibrat ion curves of ssDNA (CS, C6) and dsDNA (CS-C6) using 20.0 
ppm ABTS at 46S nm .  
Calibration curve of CS, C6, ds(CS,C6), and cl·DNA using AzBTS (20 ppm, pH 7, 680 nm) 
800 
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0 0 2 0 4  0 6 0 8  
Nueliee acid Cone. ug/ml --- ----
1 2  1 4  
___ CS + AzBTS 
- - ds(C6.CS) + 
AzBTS 
-- el-DNA + 
AzBTS 
Fig. 4 . 2 .2 . 3b .  Ca l i brat ion curves of ssDNA (CS' C6)' dsDNA (CS-C6) and ct-DNA 







E 600 c: <> co .... 500 � 






Re ulrs and Di<;cussionlFluorimetry 
Calibration curve of C5, C6, ds(C5,C6), and ct-DNA using AzBTS (20 ppm, pH 7, 780 nm) 
0 2  0 4  0 6  0 8  
Nucleic acid Cone. ug/ml 
1 2  1 4  
-+-C5 . AzBTS 
__ C6 + AzBTS 
- - ds(C6,C5) + 
AzBTS 
- et-DNA • 
AzBTS 
Fig .  4 .2 .2 .3c .  Ca l ibrat ion curves of ssDNA (CS ' C6), dsDNA (CS-C6) and ct-DNA 
using 20.0 ppm A BTS at 780 nm.  
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Table.  4 .2 .2 . 3  L i near ranges, regress ion equat ions, detect ion l i m its and correlat ion 
coefficients characterist ics for nuc le ic  acids ca l i bration graphs us ing A BTS . 
ucleic ac id 
At 465 11 m 
ssD A (C5) 
A t  680 11 m  
ssDNA (C5) 
ssD A (C6) 
dsD A (CyC6» 
Ct-D A 
A t  780 11 m  
ssD A (C5) 
ssD A (C5) 
Ct-D A 
Linear ranges 
().lg/m l )  
0 .2- 1 . 1 8  
0 .2- 1 . 1 8  
0 .2- 1 . 1 8  
0 .2- 1 . 1 8  
0 .2- 1 . 1 8  
0 .2- 1 . 1 8  
0 .4- 1 . 1 8  
0 .2- 1 . 1 8  
0 . 2- 1 . 1 8  
0 .2- 1 . 1 8  
0 .4- 1 . 1 8  
Linear regression 
equations) 
Y=-524 . 37X+8 1 6.6 
Y=-686.05X+ 1 045 .8  
Y=-592 .7 I X+ 1 0 1 2 .9 
Y=-559.50X+7 1 0 .82 
Y=-573 .9 1 X+776.77 
Y=-582 . 38X+794 .25 
Y=-27 1 . 3 1 X+ 387.44 
Y=-73 7.07X+920.4 
Y=-8 1 1 .39X+ 1 05 3 . 1  
Y=-8 1 2 . 5 1 X+ J 029. J 







0. 1 7  
0. 1 6  
0. 1 6  
0 .35  
0.0 1 
0 .0 1 
0.0 1 
0.02 
Reported va lues are for cal ibrat ion graphs at 465 nm and 670 nm . 
s lope 
524 .37  0.96 
686.05 0 .96 
592 . 7 1 0 .96 
559 .50 0 .98  
573 .9 1 0 .98 
582 . 38  0 .94 
2 7 1 . 3 1  0.95 
737.07 0 .97 
8 1 1 .39  0 .98  
8 1 2 . 5 1 0 .96 
4 1 6 . 82 0.95 
a 
Detection l i m its were ca lcu lated using (30s)/R where Os i s  the standard dev iat ion of the blank 
and R is the slope of the ca l  ibrat ion curve. 
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Table.  4 .2 .2 .4 .  Determ inat ion resu l ts of DNA and ct-DNA based on the 465, 680 and 780 
nm using ABT 
ucleic ac id Concentrat ion ( J..lglm I )  Found ( J..lglml)  Recovery% R . S . Da 
a) At 465 o m  
ssDNA (C5) 1 . 00 1 . ] 0  1 1 0 .0 1 0.00 
ssDNA (C6) 1 .00 0.95 95 .00 5 .00 
dsD A (CS-C6» 1 .00 l .OS 1 05 .00 5 .00 
Ct-DNA 1 .00 0.96 96.00 1 0 .00 
A t  680 n m  
ssD A (Cs) 1 . 00 1 . 00 1 00.00 8 . 50  
ssDNA (C6) 1 . 00 l .OS 1 05 .00 7 .40 
dsDNA (CS-C6» 1 .00 0 .95 95 .00 9 .00 
Ct-D A 
1 .00 0.93 93 .00 1 2 .00 
At 780 o m  
ssDNA (CS) l . 00 1 . 00 1 00.00 9.00 
ssDN A  (C6) 1 .00 0.98 98 .00 6 .02 
dsD A (CS-CS» 1 . 00 1 . 05 1 05 .00 5 .00 
Ct-DNA 
1 .00 0.96 96.00 1 0 .00 
a 
Relative standard deviations ( RSD) are based on the average of at least three determinat ions. 
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4. 2. 2. 5. Binding Site alld A ociation Constants 
Fig . 4 .2 . 2 . S  show the binding curves at 46S ,680, and 780 nm for the synthet ic  
ssD A (CS ), sDNA (C6), dsDNA (CS-C6) and ct-DNA with A BTS as defined by 
equat ion 2. The assoc iat ion constants (K) to invest igated drugs and compounds and 
number of b ind ing s i tes on a nucleotide residue (n) for synthetic and natural ssDNA 
and dsD A were est imated from the slopes and intercepts and g iven in Table 4 .2 .2 . S .  
[ 1 1 4- 1 1 S ] .  A ssociat ion constants in  the range of 9.0x I OS-3 .0x I 06 were obta ined for 
the ssD s intercalates with ABTS at the 46S, 680 and 780 nm fluorescence bands. 
Correspond ing val ues for dsDNA are in the range of 8 .0x 1 0S -3 .0x 1 06. Va lues for ct­
DNA are in  the range of  6.0x 1 OS -S .Ox 1 06 . Using molar concentrat ions of 2 .39x l 0-6 
M of ssD A (Cs ), ssDNA (C6), dsDNA (CS -C6), and ct-DNA.  B i nd ing s i tes in  the 
ranges of 0.002-0 .0 1 0.002-0. 1 1 , 0 . 0 1 S-0. 1 3 , and 0.08-0. 1 3  were respect ive ly 
obtai ned (Tab le 4 .2 .2 .4) .  Such variations cou ld be attributed to changes in  b ind ing 
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Fig.  4 . 2 .2 .4b.  B ind ing curves for synthetic ssDNA (C6) with A BTS (20 ppm) at 465 
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Fig .  4 .2 .2 .4c .  B ind ing curves for synthetic dsDNA (CyC6) with  A BTS (20 ppm) at 
465 in ( 1) .  680 nm in ( J l ), and 780 nm in ( I l l ) .  Plotted curves are based on equation 2 .  
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Fig.  4 .2 . 2 .4d .  B ind ing curves for synthet ic ct-DNA with A BTS (20 ppm) at 465 i n  ( I ), 
680 nm in ( l I ), and 780 nm in  ( I I I ) .  Plotted curves are based on equat ion 2 .  
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able. 4 .2 .2 .5 .  B ind ing curves' s lopes (K) ,  i ntercepts corre lat ion coefficients ( R2) number of 
ind ing s ites (n) and l i near equations at 465 680 and 780 nm fluorescence"'max for the interact ion 
tween DNA and A BT 
DNA "'max 
Conc.  K i n tercept R2 E q u a t i o n  m oll! n 
C5 465 2 .39E-06 1 . 3 1  x 1 0
4 0 .97 0.98 0 . 0 1  y= - 1 .3 1X + 0.98 
C5 680 2 .39E-06 3 . 1 7 x 1 0
4 0 .34 0.95 0 . 0 1  y= -3 . 1 7X + 0 .35 
C5 780 2 .39E-06 4 .6 1 x 1 0
4 0 .82 0 .95 0. 002 y= -4 .6 1 X  + 0.83 
C6 465 2 . 39E-06 9.37 x 1 0
4 1 .03 0.99 0. 002 y= -9 . 37X + 1 .03 
C6 680 2 .39E-06 2.08 x 1 0
4 0.72 0.97 0 . 06 y= -2 .08X + 0.72 
C6 780 2 .39E-06 2 .68 x 1 0
4 0.23 0.94 0. 1 1  y= -2 .68X + 0.23 
s(C5 -C6) 465 2 . 39E-06 8 . 1 1  x 1 0
4 1 .02 1 .00 0 . 0 1  y= -8 . I I X  + 1 .03 
s(CyC6) 680 2 . 39E-06 1 . 75 x 1 0
4 0 .84 0 .97 0.03 Y= - I .  75X + 0.85 
s(C5-C6) 780 2 .39E-06 2 .90 x 1 0
4 0 .04 0 .94 0. 1 3  y= -2 .90X + 0.05 
ct-DNA 465 2 .39E-06 8.22 x 1 0
4 1 .24 0.98 0. 1 3  y= -8 .22X + 1 . 25  
ct-D A 680 2 . 39E-06 2 .99 x 1 0
4 0. 1 3  0 .95 0. 1 2  Y= -2.98X + 0. 1 3  
ct-DNA 780 2 . 39E-06 4 . 87  x J 0
4 1 .99 0.95 0 . 08 Y= -4 . 87X + 1 .99 
I I I  
::J 
� 
� (/J c Q) C 
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4. 2. 2. 6. Selectivity 
I nterference of twe lve metal ions and am ino acids on ct-DNA-ABTS intercalate 
\\as i nvest igated under cond it ions described in sect ion the experimental part. A 1 .0 m l  
of 20 �lgllml ct-D A was added to 1 .0 ml of 20 �g/m l ABTS. A 200 �l of 1 0-7 M of 
either interfering substance was added to the m ixture .  The volume was adj usted to 3 .0  
m l  using phosphate buffer pH 7 and their spectra were measured (F ig.4 .2 .2 . 5 ) .  
Fl uorescence intensi t ies a t  465 ,  680 and 780 nm were determ ined.  Resu l ts are shown 
in Tab le  4 .2 .2 . 5 .  6F% values between 1 .3 7-29.07% were obta i ned at 465 nm whereas 
a l ues of 0.0 1 -24 .34 and 0.00- 1 9 .45% were respect ively obtained at 680 and 780 nm .  
CuS04 was shown to be h ighly interfering whereas glycene was shown to  be  non 
interfering. H owever since most of these interferants can be e l im i nated dur ing DNA 
purification, a good se lect iv i ty exists in  deve loped i nteract ion between A BTS and ct-
DNA .  







500 600 700 800 
Wavelength (nm) 
Fig.  4 .2 .2 . 5 .  F luorescence spectra obtained by add ing 200 �I of 1 0.
7 M CUS04 in 
phosphate buffer p H  7 to a m ixture of 1 .0 m l  (20 �g/m l) ct-DNA and 1 .0 m l  (20 
�g/m l )  ABTS. Spectra were measured at exci tation wavelengths of 235  n m  i n  ( 1 )  3 3 5  
nm in 465 i n  ( I I )  and 3 90 nm ( J I l ) .  
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Fig. 4 .2 .2 .6 .  F l uorescence spectra obta i ned by add ing 200 III of 1 0-7 M glycene i n  
phosphate buffer pH 7 to  a m i xture of 1 .0 m l  ( 20  Ilg/m l)  ct-DNA and  1 .0 m l  (20 
Ilg/m l )  A BTS . Spectra were measured at exci tat ion wave lengths of  235 nm in ( 1 )  3 3 5  
n m  i n  465 in  ( I I )  and 390 n m  ( I l l ) .  
1 1 3 
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Table .  4 .2 .2 .6 .  Effects of some i nterfering solut ions on A BTS-ct-DNA in terca late in  
phosphate buffer pH 7 .  A 1 0-7 M i nterfering sol ut ions were used .  
I nterfe r i n g  Cone.  
LlF% 
substance moll 
465 nm 680 nm 780 nm 
A lanine 6 .67E-09 -4 .93 1 0 . 1  1 9.45 
CaC I2 6 .67E-09 6 .60 - 1 3 . 72 0.00 
CdCI2 6 .67E-09 - 1 . 79 6 . 1 2  7 . 1 3  
CoC I2 6 .67E-09 - 1 . 37  0 .0 1 2 .03 
CuS04 6.67E-09 h igh h igh h igh 
FeS04 6 .67E-09 9 .7 1 h igh h igh 
G lyc ine 6 .67E-09 2 1 .67 - 1 7 . 1 0  - 1 0 .25 
HgC l4 6 .67E-09 -6 .83 -2 .25  -0.43 
D-L-Va l ine 6 .67E-09 29.07 -5 .70 -4 . 73 
Mn 04 6.67E-09 1 1 .29 -24 . 34  - 5 .95 
Pb(N°3h 6. 67E-09 1 1 5 . 1 9  -72 . 3 1 -47.79 
ZnC '2 6 .67E-09 4 . 84 - 1 3 .60 -6 .22 
1 1 4 
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4. 2. 2. 6. Di cu ion of interaction mechanism 
L igand molecu les b ind nucle ic ac ids in e lectrostat ic groove and intercalat ion 
ways. tructure planarity i s  a vital  factors requ i red for an e ffic ient i nterca lat ive 
mechan ism [45 ] .  Quench ing the fluorescence intens i ty i s  an ev idence of intercalat ing 
l igand molecu les into the stack ing base pai rs of nucleic ac ids  [46] .  ABTS i n  i ts 
reduced form i s  negat i ve ly charged part ic les. Therefore, b ind i ng of A BTS with 
invest igated ssDNA and dsDNA nucle ic ac ids can be assumed to occur in  groove 
binding intercalat ion mechan ism . 
4. 2.2.7 .  C o n c l us ions 
I n  phosphate buffer pH 7 ssDNA, dsDNA with 20 and 40 base pairs as we l l  as 
ct-D A have shown to interact with r ifampicin and A BTS at room temperature 
resu l t ing in  decreasing the fluorescence intensit ies at 475,  670, 465,  680 and 780 nm .  
Linear ca l ibration graphs  for synthetic ssDNA, dsDNA as  we l l  a s  ct-DNA in the 
range of 1 .6-5 . 5 7  and 0 .2- 1 . 1 8 Ilglm l with detection l i m i ts of  0 .43-0 .45 and 0 .0 1 -0 .35  
were obta i ned, respect ively.  
DNA in  extraction products from ca lf  thymus was tested and sati sfactory 
recoveries were obta i ned . The associat ion constant and number of  b ind ing s i tes on 
synthetic ssDNA and dsDNA as wel l  as ct-DNA were est imated us ing the Rosenthal ' s 
graph ical method .  
New fl uoremetric methods for determ in ing DNA based on interca lates wi th  
ri fampic in  and A BTS were developed . Developed methods have shown good 
rel i abi l ity, sensi t iv i ty ,  rapid ity and reproduc ib i l i ty .  An i nterca l at ion interaction 
mechan ism was proposed for the b ind ing mode of DNA with r i fampic in  drug. A 
groove b ind ing interaction mechanism m ight be proposed for the DNA interaction 
with A BTS. Reaction of ABTS with ct-DNA has shown to be selecti ve with less 
interference from some cations and am ino acids tested . 
1 1 5 
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A- � J  added ver us absorbance 
1 - Addit ion of D I I to 5 - iodo-2 -deoxyurid ine. 
J.l 1  added of nucleic acid Absorbance at 260 run Absorbance at 2 8 5  nm 
1 00 J.l1 0. 1 3  0.20 
200 J.l1 0. 1 4  0. 1 9  
300 J.l 1 0. 1 4  0. 1 8  
400 J.l 1  0. 1 5  0. 1 7  
500 J.l1  0. 1 5  0. 1 6  
600 III 0. 1 5  0. 1 5  
700 III 0. 1 6  0. 1 5  
800 III 0. 1 6  0. 1 5  
900 III 0. 1 6  0. 1 4  
1 000 III 0. 1 6  0. 1 4  
1 1 00 III 0. 1 6  0. 1 3  
1 200 J.l1  0. 1 6  0. 1 3  
1 3 00 III 0. 1 7  0. 1 3  
1 400 III 0. 1 7  0. 1 3  
1 5 00 J.l 1  0. 1 7  0. 1 2  
1 600 J.l 1  0. 1 7  0. 1 2  
1 700 J.l 1  0. 1 7  0. 1 2  
1 800 J.l l  0. 1 7  0. 1 2  
1 900 J.l1  0. 1 7  0. 1 2  
2000 J.l1 0. 1 8  0. 1 J 
2- Addit ion of ds(D )  ) -D ) 2) to 5 - iodo-2 -deoxyurid ine .  
III added o f  nucleic acid A bsorbance at 260 nm Absorbance at 2 8 5  nm 
) 00 III  0. 1 3  0.2 ) 
200 III 0. 1 3  0.20 
300 fll 0. 1 4  0.20 
400 fll 0. 1 4  0. 1 9  
500 III  0. 1 4  0. 1 8  
600 fll 0. 1 5  0. 1 7  
700 II I  0. 1 5  0. 1 7  
800 III 0. 1 5  0. 1 7  
900 fl l 0. 1 6  0. 1 6  
1 000 II I  0. 1 5  0. 1 6  
1 1 00 fl l  0. 1 5  0. 1 5  
1 200 III  0. 1 5  0. 1 5  
1 3 00 fll 0. 1 6  0. 1 4  
1 400 fll 0. 1 6  0. 1 5  
1 500 III 0. 1 6  0. 1 4  
1 600 III 0. 1 6  0. 1 4  
1 700 II I  0. 1 6  0. 1 4  
1 800 III  0. 1 6  0. 1 4  
1 900 fl l  0. 1 6  0. 1 3  
2000 II I  0. 1 6  0. 1 3  
3 - Addi t ion of 5 - iodo-2 -deoxyurid ine to ct-DNA.  
p I  added o f  nucleic acid Absorbance at 260 nm Absorbance at 2 8 5  run 
1 00 p I  0.20 0. 1 0  
200 p I  0. 1 9  0. 1 2  
300 p I  0. 1 8  0. 1 2  
400 p I  0. 1 9  0. 1 4  
600 p I  0. 1 7  0. 1 6  
800 p I  0. 1 7  0. 1 7  
1 000 p I  0. 1 7  0. 1 8  
1 200 p I  0. 1 6  0. 1 9  
1 400 p I  0. 1 6  0. 1 9  
1 600 p I  0. 1 6  0.20 
1 800 pI 0. 1 5  0.2 1 
2000 II I  0. 1 5  0.2 1 
4- Addit ion of Cs to A BTS . 
J.II added of nucleic acid Absorbance at 260 nm Absorbance at 340 nm 
1 00 J.II 0. 1 2  0.32 
200 J.II 0. 1 3  0.29 
400 J.II 0. 1 4  0.25 
600 III 0. 1 5  0.22 
800 II I 0. 1 6  0. 1 9  
1 000 J.II  0. 1 6  0. 1 8  
1 200 J.II 0. 1 7  0. 1 5  
1 400 J.II 0. 1 7  0. 1 4  
1 600 III 0. 1 7  0. 1 3  
1 800 III  0. 1 7  0. 1 2  
2000 J.II  0. 1 7  0. 1 2  
5- Addi t ion of C6 to ABTS. 
III added o f  nucleic acjd Absorbance at 260 nm Absorbance at 340 nm 
1 00 III  0. 1 6  0.40 
200 III 0. 1 6  0.38 
400 III 0. 1 7  0.33 
600 II I  0. 1 7  0.28 
800 III 0. 1 8  0.25 
1 000 III 0. 1 8  0.23 
1 200 III 0. 1 9  0.20 
1 400 III 0. 1 9  0. 1 8  
1 600 II I  0. 1 9  0. 1 7  
1 800 III  0. 1 9  0. 1 6  
2000 II I  0. 1 9  0. 1 5  
6- Add i t ion of ds(CS-C6) to ABTS. 
111 added of nucleic acid Absorbance at 260 nm Absorbance at 340 nm 
1 00 J-II  0. 1 5  0.40 
200 J-II 0. 1 6  0 .37  
400 II I  0. 1 7  0 .32 
600 1-11 0. 1 7  0 .28 
800 III  0. 1 8  0.25 
1 000 II I  0. 1 8  0.22 
1 200 1-11 0. 1 8  0.2 1 
1 400 1-11 0. 1 8  0.20 
1 600 1-1 1 0. 1 9  0. 1 8  
1 800 1-1 1 0. 1 9  0. 1 7  
2000 1-11 0. 1 9  0. 1 6  
7- Addit ion of  ct-DNA to ABTS. 
� I  added o f  nucleic acid  Absorbance at  260 run Absorbance at 340 run 
1 00 )ll 0. 1 I 0.27 
200 J..I I  0. 1 2  0.24 
400 �I 0. 1 3  0.22 
600 J..I I 0. 1 4  0.20 
800 )ll 0. 1 5  0. 1 8  
1 000 )ll 0. 1 6  0. 1 5  
1 200 J..I I 0. 1 7  0. 1 3  
1 4 00 �I  0. 1 7  0 . 1 2  
1 600 )l 1  0. 1 8  0. 1 1  
1 800 )l l 0. 1 8  0. 1 0  
2000 )ll 0. 1 9  0.09 
8- Addit ion of levofloxacin to D 1 1 . 
III added of nucleic acid Absorbance at 260 om Absorbance at 290 nm 
1 00 III 0.2 1 0. 1 0  
200 1-'1 0.23 0. 1 6  
400 III 0.24 0 .2 1 
600 1-'1 0.26 0.25 
800 II I  0.27 0.28 
1 000 II I 0.29 0 . 3 1 
1 200 1-' 1  0.3 1 0.42 
1 400 II I  0 .32  0 .45 
1 600 III 0.33 0.47 
1 800 1-'1 0 .33  0.50 
2000 III 0.34 0.52 
9- Addi t ion of levofloxac in to ds( D l l - D 1 2) .  
� l  added of nucleic acid Absorbance at 260 nm Absorbance at 290 nm 
1 00 �I  0.24 0. 1 2  
200 III 0.24 0. 1 8  
400 III 0.30 0.29 
600 III 0.33 0.37 
800 �I 0.36 0.44 
1 000 III 0 .38 0.49 
1 200 III 0.4 1 0.55 
1 400 III 0 .44 0.59 
1 600 III  0.46 0.64 
1 800 III 0.48 0.67 
2000 III 0.5 1  0.7 1 
1 0- Addit ion of Ie ofloxacin to ct-DNA.  
).l l  added o f  nucleic acid Absorbance at 260 run Absorbance at 290 run 
1 00 ).l1 0.2 1 0. 1 I 
200 ).ll 0.23 0. 1 6  
400 ).ll 0.25 0 .25 
600 ).ll 0 .27 0 .3 1 
800 J.l1 0.28 0.35 
1 000 fll 0.29 0.40 
1 200 ).ll 0.30 0.43 
1 400 J.l1  0.3 1 0 .45 
1 600 J.l1 0.3 I 0.47 
1 800 J.l1 0.3 1 0.49 
2000 J.l1 0.32 0 .5 1 
1 1 - Addi t ion of Cs to R ifampic in .  
J.l 1  added o f  nucle ic  acid Absorbance at 260 nm Absorbance at 475 nm 
1 00 J.lI 0. 1 2  0.04 
200 J.lI 0. 1 2  0.04 
400 J.l1 0. 1 2  0.03 
600 J.l1 0. 1 2  0.03 
800 J.l1 0. 1 1  0.02 
1 000 J.l1 0 . 1 1 0 .02 
1 2 - Addi t ion of  C6 to R ifampic in .  
III added o f  nucleic acid Absorbance at 260 nm Absorbance at 475 nm 
1 00 J.l1 0. 1 3  0.05 
200 J.l1  0 . 1 4  0.05 
400 J.l1 0. 1 3  0.04 
600 J.l1 0. 1 3  0.04 
800 J.l1 0. 1 3  0.03 
1 000 J.l 1  0. 1 2  0.03 
1 3 - Addit ion of  ct-DNA to R ifampic in .  
p i  added o f  nucleic acid  A bsorbance at  260 nm Absorbance at  475 nm 
1 00 pi 0.2 1 0 . 0 1  
200 pi  0.22 0 .02 
400 pi 0 .24 0 .04 
600 pi 0 .25 0 .05 
800 pI 0.26 0.07 
1 000 p i  0 .27 0 .07 
1 200 p I  0 .28 0.08 
1 400 p I  0 .28 0.09 
1 600 p I  0 .29 0. 1 0  
1 800 p I  0 .29 0 . 1 0  
2000 pI  0 29 0 . 1 0  
Appendix B 
(Fluorimetry ) 
8 - /-l l  added versus intens ity .  
1 - Addit ion of ct-DNA to R i fampic in (pH 7, 5 ppm) .  
fl l  added o f  nucleic acid  I ntensity at  470 nm Intensity at 670 nm 
200 fl l 57.38 1 7 .47 
600 fll 50.3 8 1 7 .03 
1 000 fll 43 .2 1 1 2 .69 
2- Addi t ion of ct-DNA to R i fampic in  (pH 7, 1 0  ppm). 
III added of nucleic acid I ntensity at 470 nm lntensity at 670 nm 
200 fll 49.06 22 .24 
600 fl l 42.42 1 6.26 
1 000 fl l 3 2 . 89 1 1 .22 
3- Addit ion of ct-DNA to R ifampic in  (pH 7, 1 5  ppm).  
III added of nucleic acid lntensity at 470 nm Intensity at  670 nm 
200 fll 36.95 1 6. 3 4  
600 fl l  30.75 1 0.93 
1 000 fll 2 1 .77 7 .53  
4- Addit ion of  ct-DNA to R ifampic in  (PH 7, 20 ppm).  
I .. t! added of nucleic aci d  I ntensity at 470 n m  I ntensity a t  670 nm 
200 J..II 30.93 1 6.67 
600 J..I I  29.63 1 4 .92 
1 000 J..I I 2 1 .70 8.56 
5- Addit i on of ct-DNA to R i fampic in  (pH 7, 30 ppm). 
J..Il added of n ucleic aci d  I ntensity at 470 n m  I ntensity a t  670 nm 
200 J..I I  28 .92 1 5 .4 1 
600 J..II 2 2 . 3 2  1 1 .3 7  
1 000 J..II 1 2 .93 6 .27  
6- Addi t ion of  ct-DNA to R i fampic in  (pH 7, 50  ppm). 
J..II added of n ucleic aci d  I ntensity a t  4 70 run I ntensity at 670 nm 
200 J..I I 1 3 .53 9 .40 
600 J..II 9.00 5 .80 
1 000 J..I I  3 . 97 2 . 85 
7- Addit ion of  ct-DNA to Rifampic in  (pH 4 1 0  ppm). 
).II added of nucleic acid  Intensity at  470 nm 
200 ).II  74.48 
600 ).II 4S .0S 
1 000 ).II 34 .77 
8- Addit ion of ct-DNA to R i fampic in (PH 5 ,  1 0  ppm). 
)ll added of nucleic acid Intensity at 470 nm 
200 f.1l 47. 1 6  
600 ).I I 3 7 . 83 
1 000 f.1l 27.90 
9- Addit ion of  ct-DN A  to Rifampic in  (pH 6, ] 0 ppm). 
f.11 added of nucleic acid Intensity at 470 nm 
200 ).II 44.42 
600 ).II  39.79 
1 000 f.1 l 26.46 
I ntensity at 670 nm 
20. 1 9  
1 7 .36 
1 2 .32  
Intensity at 670 nrn 
1 8 .0S 
I S .04 
9.29 
Intensity at 670 nm 
1 2 . 8 1  
1 1 .73 
8 .94 
1 0- Addi t ion of ct-DNA to R i fampic in  (PH 4 ,  50 ppm) .  
JlI added of nucleic acid I ntensity at 470 nm Intensity at 670 nm 
200 III  1 6 .59 1 5 .44 
600 II I 9.87 8 .2S  
1 000 II I 3 .68 2.97 
1 1 - Addi t ion of ct-DNA to R i fampic in  (pH 5, 50 ppm). 
fll added of nucleic acid I ntensity at 470 nm I ntensity at 670 nm 
200 II I  1 7 . 3 5  1 4 . 3 2  
600 JlI 9.54 7 .78  
1 000 JlI 3 .68 4 . 3 0  
1 2 - Addi t ion of ct-DN A  to R i fampic in  (PH 6, 50 ppm). 
III added of nucleic acid Intensity at 470 nm I ntensity at 670 nm 
200 Jl I  1 6 .7 1 1 3 .03 
600 III 9.8 1 7 . 1 6  
1 000 JlI 4 .22 2 .96 
1 3 - Addit ion of  Cs to ABT (pH 7 20 ppm). 
fil added of n ucleic  acid Intensity at 465 nm I ntensity at 680 nm Intensity at 7 80 nm 
0.0 1 III  670.70 529.63 726. 5 8  
0.02 III 657.44 499.54 679.57 
0.03 fil 5 30.63 400.40 524.05 
0.04 fil 420.50 277.58 354. 1 3  
0.05 II I 270. 1 6  1 4 1 . 1 5  1 66.2 1 
0.06 fil 23 8.84 1 00.80 1 04.09 
0.07 fi l  2 29.29 82. 1 7  72 .42 
1 4- Add i t ion of C6 to ABTS (pH 7, 20 ppm). 
J.l 1  added o f  nucleic acid Intensity at 465 nm Intensity at 680 nm Intensity at  780 n m  
0.0 1 )11 959.96 683 .70 9 1 7.79 
0.02 )11 77 1 .69 559.53 748.76 
0.03 )11 593.74 4 1 6.66 548.60 
0.04 )11 5 8 1 .95 403 .29 529.40 
0.05 III 368.23 200.07 246.55 
0.06 III 3 2 7 . 86 1 69.53 1 89.54 
0.07 III 303 .64 1 1 5 .76 1 1 4 .02 
0.08 fil 266.76 1 1 0.09 83 .06 
1 5 - Addi t ion of ds(CS-C6) to ABTS (pH 7, 20 ppm). 
J.lI added of nucleic acid Intensity at 4 65 nm Intensity at 6 80 nm I ntensity at 780 nm 
0.0 1 fil 1 000.00 729. 1 7  92 5 . 7  
0.02 fil 796.07 572.63 720. 1 3  
0.03 J.l1 626.24 397 . 1 0  48 1 .97 
0.04 )11 507.58 294. 7 8  3 5 3 .99 
0.05 fil 428 .74 23 1 .50 243 .30 
0.06 fil 40 1 .64 1 95 .38  1 77.98 
0.07 fil 334.69 1 3 5 .45  1 1 1 . 87  
0.08 fi\ 3 1 7 .50 1 1 2 .46 82.78 
1 6- Addit ion of ct-DNA to A BTS (PH 7 20 ppm). 
III added of nucleic acid Intensity at 465 nm Intensity at 680 nm Intensity at 780 nm 
0.0 1  III 767 . .  2 2  5 3 1 .33  72 4 .80 
0.Q2 III 6 1 8 . 89 40 1 .49 542 .36 
0.03 III 499.97 267.0 1 392.36 
0.04 III 459.06 229. 1 3  280.33 
0.05 III 400.35 1 78 .40 207.86 
0.06 III 3 2 4 .92 1 49.90 1 68.66 
0.07 III 3 3 0.4 1 1 36.63 1 49.25 
0.08 III 2 9 1 . 84 1 3 1 .25  1 3 2 . 74 
1 7- Addi t ion of Human DNA to ABTS (PH 7, 20 ppm). 
III added o f  nucleic acid Intensity at 465 nm Intensity at 680 n m  Intensity a t  780 n m  
0.0 1 II I  920.53 509.95 724.92 
0.02 III 720.99 294.95 3 8 7.04 
0.03 III 4 80.75 1 97.79 248.77 
0.04 III  363 . 82 1 45.43 1 68 . 0 1  
0.05 III 344. 1 4  1 78.40 1 5 8. 1 9  
0.06 III 289.77 1 1 4 .83 1 07.07 
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